# Abdominal Radiology

## Identity
- **Abbreviation:** Abdom Radiol
- **Publisher:** Springer Nature (Society of Abdominal Radiology)
- **ISSN:** 2366-004X / 2366-0058
- **Homepage:** https://www.springer.com/journal/261
- **Author guidelines:** https://www.springer.com/journal/261/submission-guidelines

## Scope
Abdominal Radiology publishes original research, reviews, and case studies focused on imaging of the abdomen and pelvis, including the gastrointestinal tract, liver, pancreas, biliary system, kidneys, adrenal glands, and genitourinary system. All imaging modalities are covered, with emphasis on CT, MRI, and ultrasound of abdominal organs.

## Scope Keywords
abdominal imaging, liver imaging, pancreas imaging, renal imaging, gastrointestinal imaging, CT abdomen, MRI abdomen, hepatocellular carcinoma, colorectal cancer, kidney tumor, adrenal imaging, biliary imaging, pelvic imaging, genitourinary imaging, contrast-enhanced ultrasound

## Article Types Accepted
- Original Article
- Review Article
- Pictorial Essay
- Case Report (as Brief Report)
- Technical Innovation
- Letter to the Editor

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Springer transformative agreements)
- **Field:** Radiology / Abdominal imaging

## Special Notes
Abdominal Radiology is the official journal of the Society of Abdominal Radiology (SAR). It was formed by the merger of the abdominal imaging sections of Journal of Computer Assisted Tomography and the former Abdominal Imaging journal. The journal regularly publishes themed issues and disease-focused supplements. It is a strong home for LI-RADS, PI-RADS, and other structured reporting studies.

# Academic Radiology

## Identity
- **Abbreviation:** Acad Radiol
- **Publisher:** Elsevier (Association of Academic Radiology)
- **ISSN:** 1076-6332 / 1878-4046
- **Homepage:** https://www.academicradiology.org/
- **Author guidelines:** https://www.elsevier.com/journals/academic-radiology/1076-6332/guide-for-authors

## Scope
Academic Radiology publishes original investigations, clinical reviews, and innovations in radiology education, health services research, imaging informatics, and quality improvement, with emphasis on the academic mission of radiology departments.

## Scope Keywords
radiology education, health services research, imaging informatics, quality improvement, AI in radiology, medical imaging, radiology training, diagnostic accuracy, imaging policy, radiology workforce, machine learning, patient safety, clinical decision support, imaging utilization, evidence-based radiology

## Article Types Accepted
- Original Investigation
- Clinical Review / Systematic Review
- Innovations
- Perspectives
- White Papers
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Radiology / Education / Health services

## Special Notes
Academic Radiology is the official journal of the Association of University Radiologists (AUR) and the Alliance of Medical Student Educators in Radiology (AMSER). It uniquely bridges clinical radiology research with education, informatics, and practice management. Double-blind review process with mandatory AI declaration. AI policy: language editing only, Methods disclosure required per ICMJE.

# American Journal of Kidney Diseases

## Identity
- **Abbreviation:** Am J Kidney Dis
- **Publisher:** Elsevier (NKF)
- **ISSN:** 0272-6386 / 1523-6838
- **Homepage:** https://www.ajkd.org
- **Author guidelines:** https://www.ajkd.org/content/authorinfo

## Scope
AJKD is a premier clinical nephrology journal, publishing clinical investigations, epidemiologic studies, health services research, clinical trials, and educational articles. It is highly valued for translating clinical research into actionable kidney care.

## Scope Keywords
clinical nephrology, chronic kidney disease, acute kidney injury, hemodialysis, peritoneal dialysis, kidney transplantation, hypertension, cardiorenal syndrome, glomerulonephritis, electrolyte disorders, mineral bone disorder, health policy, clinical practice, teaching cases, kidney stones

## Article Types Accepted
- Original Investigation
- Research Letter
- Review
- Teaching Case
- Editorial

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Nephrology (clinical)

## Special Notes
AJKD (IF ~10.4) requires a highly specific structured abstract (max 300 words) with headings like Rationale & Objective, Setting & Participants, Predictors, Outcomes, Measurements, and Limitations. Requires a Clinical Summary section at the beginning. AI policy: language editing only, disclose before references, AI images banned.

## Verification
- **Source:** AJKD Information for Authors — https://www.ajkd.org/article/S0272-6386(11)01206-6/fulltext
- **Date:** 2026-07-14
- **Note:** the 300-word abstract limit is quoted verbatim from that page in the PR #330 review (https://github.com/Aperivue/medsci-skills/pull/330#issuecomment-4968075916). The 3,500-word body limit was confirmed on the same page.

# American Journal of Neuroradiology

## Identity
- **Abbreviation:** AJNR Am J Neuroradiol
- **Publisher:** American Society of Neuroradiology (ASNR)
- **ISSN:** 0195-6108 / 1936-959X
- **Homepage:** https://www.ajnr.org/
- **Author guidelines:** https://www.ajnr.org/page/authors

## Scope
AJNR publishes original research, reviews, and technical innovations in diagnostic and interventional neuroradiology, covering brain, spine, and head/neck imaging across all modalities including advanced MRI techniques, functional imaging, and AI applications in neuroradiology.

## Scope Keywords
neuroradiology, brain imaging, spine imaging, head and neck imaging, cerebrovascular disease, stroke imaging, brain tumor, glioma, MR spectroscopy, diffusion tensor imaging, functional MRI, pediatric neuroimaging, neurodegenerative disease, white matter disease, AI neuroradiology, perfusion imaging

## Article Types Accepted
- Original Research
- Review Article
- Technical Note
- Case Report
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Neuroradiology

## Special Notes
AJNR is the flagship journal of the American Society of Neuroradiology and covers both diagnostic and interventional neuroradiology (though purely interventional papers may fit INSI better). Requires a unique "What This Adds to the Published Literature" box with 3 bullet points. AI policy: follows ICMJE — disclose AI use in Methods.

# American Journal of Roentgenology

## Identity
- **Abbreviation:** AJR Am J Roentgenol
- **Publisher:** American Roentgen Ray Society (ARRS)
- **ISSN:** 0361-803X / 1546-3141
- **Homepage:** https://www.ajronline.org/
- **Author guidelines:** https://www.ajronline.org/page/authors

## Scope
AJR publishes original research, reviews, and technical innovations across all subspecialties of diagnostic radiology, with strong emphasis on clinical imaging practice, diagnostic accuracy studies, and AI applications in medical imaging.

## Scope Keywords
diagnostic radiology, body imaging, CT, MRI, ultrasound, abdominal imaging, thoracic imaging, musculoskeletal imaging, breast imaging, genitourinary imaging, pediatric radiology, AI in radiology, diagnostic accuracy, imaging biomarkers, contrast media, interventional radiology

## Article Types Accepted
- Original Research
- Brief Report
- Review Article
- Pictorial Essay
- Technical Innovation
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Radiology (general)

## Special Notes
AJR is one of the oldest and most widely read general radiology journals, published by ARRS since 1906. It requires both a "What Does This Article Add?" box and "Key Points" for original research. Strong emphasis on clinical relevance and practical applicability of findings. AI policy: follows ICMJE — disclose AI use in Methods.

## Acceptance Signals
- **Selectivity band:** selective
- **Desk-reject triggers:** limited clinical relevance or practical applicability; incremental work that cannot fill a concrete "What Does This Article Add?" statement
- **Design expectations:** clinically grounded diagnostic-accuracy or imaging studies with a clearly articulated contribution
- **Study-type tolerance:** original research, brief reports, and technical innovations valued when clinically actionable
- **Review process:** mandatory "What Does This Article Add?" box + Key Points; ICMJE AI disclosure
- **Cascade / transfer:** tier-down to a specialty or subspecialty radiology journal

# Annals of Internal Medicine

## Identity
- **Abbreviation:** Ann Intern Med
- **Publisher:** American College of Physicians (ACP)
- **ISSN:** 0003-4819 / 1539-3704
- **Homepage:** https://www.acpjournals.org/journal/aim
- **Author guidelines:** https://www.acpjournals.org/journal/aim/authors

## Scope
Annals of Internal Medicine publishes original research, systematic reviews, clinical guidelines, and essays relevant to internal medicine and its subspecialties. It values rigorous methodology, clinical relevance, and findings that directly inform patient care. Known for publishing the TRIPOD and STARD statements, the journal has strong standards for diagnostic accuracy and prediction model reporting.

## Scope Keywords
internal medicine, clinical outcomes, diagnostic accuracy, prediction models, systematic review, evidence-based medicine, screening, therapeutics, prevention, health services research, quality improvement, clinical guidelines, patient safety, epidemiology, biostatistics

## Article Types Accepted
- Original Research
- Systematic Review
- Research Letter
- Review
- Ideas and Opinions
- Clinical Guidelines
- In the Clinic
- Beyond the Guidelines
- On Being a Doctor (narrative)

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (optional OA)
- **Field:** General / internal medicine

## Special Notes
Annals is the only major general medical journal to require a "Limitation" heading in the structured abstract. It enforces double-blind peer review with dedicated statistical reviewers. Known for rigorous TRIPOD compliance in prediction model papers. If rejected, authors can request transfer to ACP's Annals of Family Medicine. Visual abstracts are encouraged for social media visibility. The journal also publishes "Summaries for Patients" companion pieces for all original research.

# Artificial Intelligence in Medicine

## Identity
- **Abbreviation:** Artif Intell Med
- **Publisher:** Elsevier
- **ISSN:** 0933-3657 / 1873-2860
- **Homepage:** https://www.sciencedirect.com/journal/artificial-intelligence-in-medicine
- **Author guidelines:** https://www.elsevier.com/journals/artificial-intelligence-in-medicine/0933-3657/guide-for-authors

## Scope
Publishes original research on AI techniques applied to medicine, emphasizing methodological novelty beyond mere application of known algorithms to medical data. Covers knowledge-based systems, machine learning, NLP, and decision support with demonstrated clinical relevance.

## Scope Keywords
artificial intelligence, machine learning, clinical decision support, natural language processing, knowledge representation, medical informatics, deep learning, explainable AI, predictive modeling, electronic health records, computer-aided diagnosis, clinical NLP, Bayesian networks, reinforcement learning, medical reasoning

## Article Types Accepted
- Original Research
- Methodological Review/Survey
- Position Paper
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Medical AI / Health informatics

## Special Notes
Premier AI-in-medicine journal requiring genuine methodological novelty — not just applying existing algorithms to medical data. Clinical assessment strongly recommended. Single-blind review; median first decision ~12 days. AI policy: AI-generated images not permitted in artwork; follows ICMJE for AI text disclosure.

# BJR Case Reports

## Identity
- **Abbreviation:** BJR Case Rep
- **Publisher:** British Institute of Radiology (BIR), published by Oxford University Press
- **ISSN:** 2055-7159 (electronic)
- **Homepage:** https://academic.oup.com/bjrcr
- **Author guidelines:** https://academic.oup.com/bjrcr/pages/general-instructions

## Scope
The case-report companion to the British Journal of Radiology, dedicated to **imaging-led case reports**
across all radiology subspecialties and modalities (radiography, ultrasound, CT, MRI, nuclear
medicine/PET, and interventional radiology). Strong fit for instructive imaging findings, rare
presentations, diagnostic pitfalls/mimics, and image-guided procedures or complications.

## Scope Keywords
radiology case report, imaging findings, diagnostic pitfall, multimodality imaging, interventional radiology, nuclear medicine, PET/CT, rare imaging presentation, structured reporting, image-guided procedure

## Article Types Accepted
- Case Report
- Case Series
- (imaging-focused) Pictorial / instructive case

## Classification
- **Tier:** Q3/Q4 (radiology case-report-dedicated)
- **Open Access:** Full gold OA, CC BY 4.0 (APC applies — verify current amount)
- **Field:** Radiology / medical imaging

## Special Notes
Radiology-society home for the imaging case that a general case-report journal cannot showcase. Expects
high-quality, **de-identified, annotated image panels**, explicit **per-modality technique→findings→
impression** description, and use of structured-reporting categories where applicable. Patient consent
for publication of images is required. Pairs with `write-paper` `exemplar_case_report_radiology.md`
and `make-figures` `exemplar_plots/imaging_panel.md`.

## Verification
Identity (BIR/Oxford, ISSN 2055-7159, CC-BY, imaging case-report scope) verified 2026-06-15 against a
current CC-BY article in the journal (Europe PMC). Specific word/figure/reference limits and the
current APC were not independently fetched — confirm at the author-guidelines URL before submission.

# BMC Medicine

## Identity
- **Abbreviation:** BMC Med
- **Publisher:** BioMed Central (Springer Nature)
- **ISSN:** 1741-7015
- **Homepage:** https://bmcmedicine.biomedcentral.com/
- **Author guidelines:** https://bmcmedicine.biomedcentral.com/submission-guidelines

## Scope
BMC Medicine is a broadly scoped, open access journal that publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health science, and global health. It prioritizes studies that advance clinical understanding, inform health policy, or provide important evidence synthesis relevant to a wide medical audience.

## Scope Keywords
clinical research, translational medicine, global health, epidemiology, public health, systematic review, meta-analysis, clinical trials, health policy, evidence synthesis, precision medicine, infectious disease, chronic disease, health services, diagnostic accuracy

## Article Types Accepted
- Research Article
- Systematic Review and Meta-Analysis
- Research in Context (commissioned)
- Opinion
- Commentary
- Correspondence
- Study Protocol

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (APC ~$3,690)
- **Field:** General medicine

## Special Notes
BMC Medicine is one of the leading fully OA general medicine journals (IF ~7-9). Fast peer review (~30 days first decision). Registered reports supported. Strong in systematic reviews and multi-site clinical studies. EQUATOR network reporting guidelines strictly enforced. Accepts transfers from other BMC journals. AI policy: follows ICMJE — disclose AI use in Methods.

# BMJ Case Reports

## Identity
- **Abbreviation:** BMJ Case Rep
- **Publisher:** BMJ Publishing Group
- **ISSN:** 1757-790X (electronic)
- **Homepage:** https://casereports.bmj.com/
- **Author guidelines:** https://casereports.bmj.com/pages/authors/

## Scope
One of the largest dedicated case-report repositories, covering case reports across all clinical specialties, with structured article types aimed at clinical learning. Strong emphasis on educational value, patient consent, and global relevance.

## Scope Keywords
case report, clinical learning, rare disease, novel diagnostic/therapeutic, reminder of important clinical lesson, images in medicine, global health, all specialties

## Article Types Accepted
- Case Report
- Images In… (image-led short report)
- Case Reports of "Reminder of important clinical lesson", "Novel diagnostic/therapeutic technique", "Unusual presentation of more common disease/injury", "Rare disease", "Findings that shed new light on the possible pathogenesis", "Unexpected outcome", "Learning from errors"
- Global Health case reports

## Classification
- **Tier:** Q3 (case-report-dedicated, high volume)
- **Open Access:** Fellowship-membership model (institutional or individual annual fellowship grants submission/publication rights) rather than a per-article APC
- **Field:** General clinical medicine / case reports (all specialties)

## Special Notes
**Patient consent is mandatory on the journal's own BMJ consent form** (not just a generic statement) — this is the most common reason submissions stall. Article-type taxonomy is explicit; choose the category that matches the teaching point. Membership model can be cost-free to authors at subscribing institutions.

## Verification
Scope, article-type taxonomy, ISSN, and the fellowship-membership/consent-form model reflect BMJ Case Reports' long-standing public model (well-established convention). The author-guidelines page returned 403 to automated fetch on 2026-06-15 and was not independently parsed — confirm the current consent-form requirement, fellowship terms, and per-type word limits at the guidelines URL before submission.

# British Journal of Radiology

## Identity
- **Abbreviation:** BJR
- **Publisher:** Oxford University Press (British Institute of Radiology)
- **ISSN:** 0007-1285 / 1748-880X
- **Homepage:** https://academic.oup.com/bjr
- **Author guidelines:** https://academic.oup.com/bjr/pages/author-guidelines

## Scope
BJR publishes original research, reviews, and pictorial reviews across all subspecialties of diagnostic radiology, interventional radiology, nuclear medicine, radiation oncology, and radiation physics, with emphasis on clinical research, methodology, and translational radiology and an explicit "Advances in knowledge" novelty framing.

## Scope Keywords
diagnostic radiology, interventional radiology, nuclear medicine, radiation oncology, radiation physics, CT, MRI, ultrasound, PET, clinical radiology, translational imaging, advances in knowledge, methodology, multi-center radiology

## Article Types Accepted
- Research Article
- Review
- Systematic Review
- Pictorial Review
- Guidelines
- Short Communication
- Commentary
- Letter to the Editor

## Classification
- **Tier:** Q2 (general radiology; verify current JCR rank)
- **Open Access:** Hybrid (optional CC BY / CC BY-NC; APC ~£2,393)
- **Field:** Radiology (general; includes physics + radiation oncology)

## Special Notes
British Institute of Radiology flagship; UK/European general-radiology readership; double-anonymized peer review (blind all upload files except title page); structured abstract requires the BJR-specific "Advances in knowledge" heading. AI policy: mandatory disclosure in both cover letter AND Methods/Acknowledgements; AI tools cannot be listed as authors; AI image generation must be disclosed.


---

## Verification
- **Source:** https://academic.oup.com/bjr/pages/author-guidelines
- **Date:** 2026-05-21

# CHEST

## Identity
- **Abbreviation:** Chest
- **Publisher:** Elsevier on behalf of the American College of Chest Physicians (ACCP)
- **ISSN:** 0012-3692 / 1931-3543
- **Homepage:** https://journal.chestnet.org/
- **Author guidelines:** https://journal.chestnet.org/content/authors

## Scope
CHEST publishes clinical research, reviews, and evidence-based guidelines in pulmonary medicine, critical care, and sleep medicine, emphasizing work with direct practice impact. Coverage spans COPD, asthma, lung cancer and nodule management, interstitial lung disease, pulmonary hypertension, venous thromboembolism, mechanical ventilation and sepsis/ARDS, sleep-disordered breathing, bronchoscopy, and chest imaging (including Lung-RADS and Fleischner-guideline research).

## Scope Keywords
pulmonary medicine, COPD, emphysema, asthma, lung cancer, lung nodule, Lung-RADS, interstitial lung disease, pulmonary fibrosis, pulmonary embolism, critical care, mechanical ventilation, ARDS, sepsis, sleep apnea, pulmonary hypertension, chest imaging, bronchoscopy, smoking cessation

## Article Types Accepted
- Original Research (unsolicited; 300-word structured abstract; 3,200 words; 50 refs)
- Research Letter (1,000 words; 10 refs)
- Systematic Review (without MA; 3,200 words; 75 refs)
- Scoping Review (3,200 words; 50 refs)
- Guidelines and Consensus Statements (4,000 words; 150 refs)
- Narrative Review (invited; 3,500 words; 75 refs)
- Special Feature (invited; 3,500 words; 75 refs)
- How I Do It (invited; 3,000 words; 50 refs)
- Point/Counterpoint + Dilemma Debate (invited)
- Editorials / CHEST Commentary (invited)
- Case sections (online only): Novel Reports, Chest Imaging & Pathology for Clinicians, CHEST Pearls, Ultrasound Corner
- Humanities in CHEST Medicine (Case-Based Discussion, Consilia Historiae, Vantage, Exhalations, Original Research)
- Letter to the Editor / Response (400 words; 5 refs)

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (APC $4,160; CC BY-NC-ND default, CC BY for mandated funders)
- **Field:** Pulmonary medicine / Critical care / Sleep medicine

## Special Notes
Flagship journal of the American College of Chest Physicians (ACCP). **Double-anonymized peer review** via Editorial Manager — submission requires separate uploads for cover letter, title page (author details), and a fully anonymized manuscript. CHEST uses distinctive terminology: "Research Question" (not Objective), "Study Design and Methods" (not Methods), and "Interpretation" (not Conclusion) in both the 6-section structured abstract and main-text section headings. A Take-Home Point pullout (3 short sentences) is required at submission. Lung imaging studies (CT screening, nodule detection AI, COPD/emphysema quantification) are well within scope when linked to clinical endpoints. **Tobacco-industry-funded research is not accepted.** Systematic reviews with meta-analysis are submitted as Original Research, not as Systematic Reviews. AI policy: generative AI disclosure required when used for readability/language — add a "Declaration of Generative AI and AI-assisted technologies in the writing process" section before the References list; AI tools cannot be authors.

<!-- Source verification: Author guidelines pasted by maintainer 2026-04-20; ISSN/publisher confirmed against journal masthead. Promoted from private tier to public on 2026-04-20. -->

# Clinical and Molecular Hepatology

## Identity
- **Abbreviation:** Clin Mol Hepatol
- **Publisher:** Korean Association for the Study of the Liver (KASL)
- **ISSN:** 2287-2728 / 2287-285X
- **Homepage:** https://www.e-cmh.org
- **Author guidelines:** https://www.e-cmh.org/authors/authors.php

## Scope
Clinical and Molecular Hepatology is the KASL flagship journal publishing original basic and clinical research on liver diseases. Particularly receptive to Korean and Asian cohort epidemiology, MASLD/NAFLD natural history, chronic hepatitis B/C management, HCC surveillance, and studies citing KASL practice guidelines.

## Scope Keywords
hepatology, liver disease, MASLD, NAFLD, MetALD, ALD, chronic hepatitis B, chronic hepatitis C, hepatocellular carcinoma, HCC, cirrhosis, liver fibrosis, FIB-4, Korean cohort, Asian epidemiology, KASL guidelines, 2023 SLD nomenclature, lean MASLD, fatty liver, liver transplantation

## Article Types Accepted
- Original Article
- Review Article (invited; unsolicited reviews accepted for peer review)
- Editorial (invited)
- Special Topic (guidelines, meeting reports, hepatology issues elsewhere)
- Letter to the Editor (online-only; within 2 years of cited article)
- Correspondence (online-only; reply to editorial)
- Research Letter (online-only; concise original study)
- Snapshot (graphical single-page summary)

## Classification
- **Tier:** Q1 hepatology
- **Open Access:** Full OA (APC US$2,000 for original/review articles submitted on/after 2026-02-01; was US$1,500 from 2024-02)
- **Field:** hepatology, observational cohort epidemiology, Korean/Asian clinical research

## Special Notes
KASL flagship journal with strong preference for Korean screening-cohort epidemiology and 2023 SLD nomenclature applications. Original articles require a mandatory graphical abstract (531×531 px, 600 dpi) and structured abstract (Background/Aims, Methods, Results, Conclusions). Fast-track review available for US$1,000 with 7-day first decision. **Blinded review**: Main Document = no author info; portal has no "Title Page" file designation, so upload title page + ICMJE forms as "Supplemental File NOT for Review". AI policy: follows ICMJE — disclose AI use in Acknowledgements with software name, version, manufacturer, dates, and description of use; AI cannot be author; citation of AI-generated material as primary source is prohibited.

# Clinical Radiology

## Identity
- **Abbreviation:** Clin Radiol
- **Publisher:** Elsevier (Royal College of Radiologists, RCR)
- **ISSN:** 0009-9260 / 1365-229X
- **Homepage:** https://www.clinicalradiologyonline.net/
- **Author guidelines:** https://www.clinicalradiologyonline.net/content/authorinfo

## Scope
Clinical Radiology publishes original research, reviews, case reports, and pictorial reviews across all areas of diagnostic and interventional radiology. As the official journal of the Royal College of Radiologists, it emphasizes clinical practice, service improvement, and evidence-based radiology with particular relevance to UK and Commonwealth healthcare systems.

## Scope Keywords
clinical radiology, diagnostic imaging, CT, MRI, ultrasound, interventional radiology, radiology practice, NHS radiology, audit, quality improvement, radiation dose, screening, radiology training, AI in radiology, radiological anatomy, pictorial review

## Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Pictorial Review
- Letter to the Editor

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Elsevier OA option)
- **Field:** Radiology / General

## Special Notes
Clinical Radiology is the official journal of the Royal College of Radiologists (RCR). British English is mandatory throughout. The journal values studies with practical relevance to UK radiology practice, including NHS audit and quality improvement work. Pictorial reviews with educational value are a strength. For European multicenter studies, consider European Radiology; for higher-impact general radiology, consider Radiology or AJR.

# Cureus

## Identity
- **Abbreviation:** Cureus
- **Publisher:** Cureus, Inc. (Springer Nature)
- **ISSN:** 2168-8184 (electronic)
- **Homepage:** https://www.cureus.com/
- **Author guidelines:** https://www.cureus.com/author_guide

## Scope
Multispecialty, online-only, open-access medical journal publishing research relevant to global healthcare, using a Continuous Article Publication model for rapid dissemination. Broadly receptive to case reports across specialties, including imaging, pharmacovigilance/adverse-event, and educational cases.

## Scope Keywords
multispecialty, case report, technical report, original research, review, rapid publication, global health, medical education, adverse drug reaction, imaging

## Article Types Accepted
- Original Article
- Review Article
- Case Report
- Technical Report
- Editorial

## Classification
- **Tier:** Q3 (multispecialty, rapid)
- **Open Access:** Full OA, CC BY 4.0; no universal APC ("zero editing fee" when formatting/language requirements are met; optional paid Preferred Editing otherwise)
- **Field:** Multispecialty medicine

## Special Notes
Requires **at least two completed independent peer reviews**; reviewers from the author's institution are excluded. Authors are asked to invite several advisers for non-peer feedback during submission. Fast turnaround and a low/zero-cost route make it a common home for student/trainee case reports — but the scientific bar (consent, de-identification, causality discipline) still applies.

## Verification
Identity, article types, OA/CC-BY, no-universal-APC model, and the two-reviewer requirement verified 2026-06-15 against the public author guide and a current CC-BY article (Europe PMC). Specific case-report word/figure limits were not stated on the fetched page — confirm at the author guide before submission.

# CardioVascular and Interventional Radiology

## Identity
- **Abbreviation:** Cardiovasc Intervent Radiol
- **Publisher:** Springer Nature (CIRSE — Cardiovascular and Interventional Radiological Society of Europe)
- **ISSN:** 0174-1551 / 1432-086X
- **Homepage:** https://www.springer.com/journal/270
- **Author guidelines:** https://www.springer.com/journal/270/submission-guidelines

## Scope
CVIR publishes original research, reviews, meta-analyses, and case reports on all aspects of cardiovascular and interventional radiology. Coverage includes vascular interventions, tumor ablation, embolization, drainage procedures, CBCT-guided interventions, and image-guided minimally invasive therapies. The journal emphasizes clinical outcomes, technical innovation, and evidence synthesis in IR practice.

## Scope Keywords
interventional radiology, embolization, ablation, vascular intervention, CBCT, cone-beam CT, drainage, stenting, angioplasty, thrombolysis, TACE, radioembolization, image-guided therapy, percutaneous biopsy, venous access, portal vein embolization, IR outcomes

## Article Types Accepted (CVIR taxonomy + limits)
- Clinical Investigation — 2400 words, structured 250-word abstract, 6 images
- Laboratory Investigation — 2400 words, structured 250, 6 images
- **Scientific Paper (Other)** — 2400 words, structured 250, 6 images — **this is the type for META-ANALYSES**
- Review Article — 3000 words, simple 125-word abstract, 10 images (includes narrative systematic reviews)
- Case Report — 1000 words, simple 125, 3 images, refs max 10
- Short Communication — 1200 words, structured 250, 3 images
- Study Protocol — 2400 words, structured 250, 3 images
- Letter to the Editor — 900 words, no abstract, 3 images, refs max 5

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Open Choice)
- **Field:** Radiology / Interventional radiology
- **Peer review:** Double-blind (anonymize the main manuscript)

## Special Notes
CVIR is the official journal of CIRSE. It readily accepts meta-analyses of IR procedures, but a **meta-analysis is the "Scientific Paper (Other)" type → 2400 words / 6 images, NOT a 3500–4000-word allowance** (a frequent miscalibration). Double-blind review: the body must be fully anonymized; all author/funding/ethics info goes on a separate Title Page with the five "Compliance with Ethical Standards" statements. Abstract: structured 250 words, **no abbreviations**, with a **Level of Evidence** line. Complication reporting must use SIR classification or Clavien-Dindo. Technical success and technique efficacy must be explicitly defined. For North American-focused IR studies, consider JVIR. Detailed profile: `write-paper/references/journal_profiles/CVIR.md`.

## Verification
- Source: CVIR Manuscript Type Manual (December 2025) + Springer Instructions for Authors.
- Last verified: 2026-06-14.

# Diabetes & Metabolism Journal

## Identity
- **Abbreviation:** Diabetes Metab J
- **Publisher:** Korean Diabetes Association (KDA)
- **ISSN:** [TODO: verify at e-dmj.org]
- **Homepage:** https://e-dmj.org
- **Author guidelines:** https://e-dmj.org/authors/authors.php

## Scope
Diabetes & Metabolism Journal is the official English-language journal of the Korean Diabetes Association covering diabetes mellitus, metabolic disorders, and endocrinology — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies addressing diabetes epidemiology, prevention, treatment, complications, body composition, metabolic syndrome, and related cohort outcomes.

## Scope Keywords
diabetes mellitus, type 2 diabetes, metabolic syndrome, body composition, sarcopenia, sarcopenic obesity, hepatic steatosis, MASLD, insulin resistance, HOMA-IR, glycaemic control, prediabetes, Korean cohort, East Asian population, KDA, diabetes prevention, diabetes complications, endocrinology, lipid disorders

## Article Types Accepted
- Original Article (4,000 words, abstract <250, refs ≤50, ≤6 figures/tables)
- Review Article (abstract <200, refs ≤150)
- Brief Report (1,500 words, abstract <180, refs ≤20, ≤2 figures)
- Editorial (refs ≤20)
- Letter to the Editor (1,000 words, refs ≤10, 1 figure or 1 table)

## Classification
- **Tier:** Q2 (specialty diabetes/endocrinology journal)
- **Open Access:** Full OA, Creative Commons Attribution Non-Commercial License (CC BY-NC)
- **Field:** Diabetes / Endocrinology / Metabolic Disease

## Special Notes
Diabetes & Metabolism Journal is the KDA flagship English-language journal, bimonthly (Jan/Mar/May/Jul/Sep/Nov). Double-blind peer review ensuring both authors and reviewers remain anonymous. Strict 4,000-word body limit for Original Article (excluding abstract, references, legends); structured abstract (Background-Methods-Results-Conclusion) ≤250 words; 3–10 MeSH keywords. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/CARE). Figure resolution ≥300 DPI in JPEG/EPS/TIFF/PICT format. AI policy: authors must disclose AI tool, version, manufacturer, and writing role on the title page; AI cannot be listed as author; AI-generated images prohibited. Particularly receptive to Korean and East Asian diabetes cohort studies and body-composition / metabolic-outcome research with single-institution observational designs.


---

## Verification
- **Source:** https://e-dmj.org/authors/authors.php
- **Date:** 2026-05-21

# Diagnostic and Interventional Radiology

## Identity
- **Abbreviation:** Diagn Interv Radiol (DIR)
- **Publisher:** Galenos Publishing House (Turkish Society of Radiology)
- **ISSN:** 1305-3825 / 1305-3612
- **Homepage:** https://www.dirjournal.org/
- **Author guidelines:** https://www.dirjournal.org/ (Instructions to Authors)

## Scope
Bimonthly, double-blind, fully open-access journal covering diagnostic and interventional radiology — original investigations, reviews, meta-analyses, pictorial essays, and technical notes across all radiology subspecialties. Indexed in SCIE, PubMed/MEDLINE, PMC, Scopus, EMBASE, DOAJ.

## Scope Keywords
diagnostic radiology, interventional radiology, imaging, CT, MRI, ultrasound, PET, angiography, embolization, biopsy, ablation, image-guided therapy, radiology AI, diagnostic accuracy, meta-analysis, technical note, pictorial essay, Turkish radiology

## Article Types Accepted
- Original Article (4500w, 400w structured abstract with PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE)
- Review Article (4000w)
- Meta-Analysis (4000w, 200w structured abstract, PRISMA flowchart required)
- Pictorial Essay (1500w)
- Technical Note (1500w)
- Letter to the Editor / Reply (500w)
- Commentary (invited, 1200w)
- Editorial (invited, 1200w)

## Classification
- **Tier:** Q2
- **Open Access:** Full OA (APC on acceptance: $1000 Meta-Analysis/Original, $1250 Review, $750 Pictorial Essay/Technical Note)
- **Field:** Radiology (diagnostic and interventional)

## Special Notes
Turkish Society of Radiology official journal; double-blind review with mandatory statistics consultant for all original articles. Editorial office desk-returns for format non-compliance — critical items include 5-subheading capitalized structured abstract (PURPOSE/METHODS/RESULTS/CONCLUSION/CLINICAL SIGNIFICANCE), 3–5 Main Points between Abstract and Introduction, explicit IRB + informed consent statements in Methods (including N/A declarations for SR/MA), parenthetical (not superscript) references in AMA style, supplementary files as Word (not PDF), and iThenticate similarity ≤20% overall / ≤5% single-source. AI policy: follows ICMJE — disclose AI use in Methods.

# Endocrinology and Metabolism

## Identity
- **Abbreviation:** Endocrinol Metab (EnM)
- **Publisher:** Korean Endocrine Society (KES)
- **ISSN:** [TODO: verify at e-enm.org]
- **Homepage:** https://e-enm.org
- **Author guidelines:** https://e-enm.org/authors/authors.php

## Scope
Endocrinology and Metabolism is the official English-language journal of the Korean Endocrine Society covering endocrinology, metabolism, hormonal disorders, thyroid, adrenal, pituitary, bone metabolism, diabetes, and lipid metabolism — clinical, epidemiological, and basic-science research. The journal is particularly receptive to Korean and East Asian population studies on endocrine disorders and to research with explicit hormonal-axis or endocrine-mechanism framing.

## Scope Keywords
endocrinology, metabolism, thyroid disorders, adrenal disorders, pituitary disorders, bone metabolism, osteoporosis, diabetes mellitus, type 2 diabetes, lipid metabolism, dyslipidaemia, metabolic syndrome, hormonal axis, hormone replacement, Korean cohort, East Asian population, KES, mineral metabolism, calcium homeostasis, endocrine oncology

## Article Types Accepted
- Original Article (abstract ≤250, refs ≤50)
- Review Article (abstract ≤200, refs ≤150)
- Brief Report (1,200 words, abstract ≤150 unstructured, refs ≤20, ≤2 figures)
- Editorial (1,000 words, refs ≤20)
- Image (1,000 words, refs ≤5)
- Letter to the Editor (1,000 words, refs ≤10, ≤1 figure)

## Classification
- **Tier:** Q2 (specialty endocrinology journal)
- **Open Access:** Full OA, content freely available
- **Field:** Endocrinology / Metabolism / Hormonal Disorders

## Special Notes
Endocrinology and Metabolism is the KES flagship English-language journal. Double-blind peer review with three anonymous specialist reviewers; review period capped at 3 months. Structured abstract (Background-Methods-Results-Conclusion) ≤250 words for Original Article. Reporting guidelines mandated per study design (CONSORT/STROBE/PRISMA/STARD). Figure resolution >300 DPI in JPEG/GIF/TIFF/BMP/PICT format with sequential Arabic numerals and letter sub-panels. AI policy: authors must clearly describe AI use in both manuscript and cover letter; AI cannot be listed as author; non-disclosure results in rejection or retraction. Particularly receptive to Korean and East Asian endocrinology studies and to research framed around hormonal-axis or endocrine-mechanism discussion. Body composition, diabetes, and metabolic syndrome research benefits from explicit endocrine framing in the manuscript narrative.


---

## Verification
- **Source:** https://e-enm.org/authors/authors.php
- **Date:** 2026-05-21

# European Journal of Preventive Cardiology (EJPC)

## Identity
- **Abbreviation:** Eur J Prev Cardiol
- **Publisher:** Oxford University Press (on behalf of the European Association of Preventive Cardiology and the European Society of Cardiology)
- **ISSN:** 2047-4881 (online)
- **Homepage:** https://academic.oup.com/eurjpc
- **Author guidelines:** https://academic.oup.com/eurjpc/pages/general-instructions

## Scope
EJPC addresses the causes and risk factors of cardiovascular diseases, as well as cardiovascular prevention, rehabilitation, exercise physiology and sport cardiology. The journal is the flagship outlet of the European Association of Preventive Cardiology (EAPC) within the European Society of Cardiology (ESC) family.

## Scope Keywords
preventive cardiology, cardiovascular epidemiology, cardiovascular risk factors, primary prevention, secondary prevention, cardiac rehabilitation, exercise physiology, sport cardiology, lifestyle medicine, lipids, hypertension, diabetes, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, subclinical atherosclerosis, cardiovascular screening, observational cohort, behavioral cardiology

## Article Types Accepted
- Full Research Paper
- Clinical Practice / Education
- Review
- Editorial
- Rapid Communication
- Letter to the Editor
- Cardialogue

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (subscription default; OA option available, APC not listed on the Author Guidelines page — verify at OUP open-access pricing portal)
- **Field:** Preventive cardiology — European society flagship

## Special Notes
Full Research Papers are capped at **5,000 words**, 6 figures/tables, and 100 references with a **structured 250-word abstract using Aims / Methods / Results / Conclusion**. References use **Vancouver numbered style with first 6 authors listed; if more than 6, use 'et al.'**. AI policy (verbatim): "Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed in a cover letter at the point of submission and explained in full in a Methods or Acknowledgements section." Submission portal: https://www.editorialmanager.com/ejpc/default.aspx. EJPC is the natural home for cardiovascular prevention studies linking risk factor clustering to incident outcomes — including CKM staging, transition pattern, and early-metabolic-window analyses. Choose EJPC over JAHA when the primary framing is preventive (transitions, screening, lifestyle) rather than general cardiovascular outcomes, and over Atherosclerosis when the cohort design and prevention narrative outweigh the lipid/plaque-biology angle.


---

## Verification
- **Source:** https://academic.oup.com/eurjpc/pages/general-instructions
- **Date (harvested from a local profile library):** 2026-05
- **Date (promoted to public):** 2026-05-21

# European Radiology

## Identity
- **Abbreviation:** Eur Radiol
- **Publisher:** Springer Nature (European Society of Radiology)
- **ISSN:** 0938-7994 / 1432-1084
- **Homepage:** https://www.springer.com/journal/330
- **Author guidelines:** https://www.springer.com/journal/330/submission-guidelines

## Scope
European Radiology publishes original research and reviews across all subspecialties of diagnostic and interventional radiology, with emphasis on multi-center studies, AI/radiomics validation, and imaging innovations relevant to European and international clinical practice.

## Scope Keywords
diagnostic radiology, interventional radiology, CT, MRI, ultrasound, radiomics, AI in radiology, multi-center studies, oncologic imaging, cardiac imaging, musculoskeletal imaging, neuroradiology, abdominal imaging, breast imaging, contrast agents, quantitative imaging

## Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (Springer Open Choice)
- **Field:** Radiology (general)

## Special Notes
European Radiology is the official journal of the European Society of Radiology (ESR) and one of the highest-impact general radiology journals. Requires 3 Key Points (max 85 characters each) as declarative statements. Uses British English throughout. Strongly prefers multi-center studies with N >= 200 for original articles. AI policy: follows ICMJE — disclose AI use in Methods. **Graphical abstract mandatory** from first revision for all Original Articles (Jan 2025). Official template: EURA-GA-Jan2025.pptx.

## Acceptance Signals
- **Selectivity band:** highly-selective
- **Desk-reject triggers:** small single-center series; case reports unless highly unusual; studies whose only novelty is a larger sample of an already-validated technique
- **Design expectations:** multi-center (international) cohorts; original articles generally expected at N ≥ 200
- **Study-type tolerance:** favors multi-center clinical and AI/radiomics validation; deprioritizes small single-center work
- **Review process:** British English; 3 Key Points; graphical abstract mandatory from first revision; ICMJE AI disclosure
- **Cascade / transfer:** Springer Nature Transfer Desk; tier-down to a specialty or society radiology journal

# Hepatology Communications

## Identity
- **Abbreviation:** Hepatol Commun
- **Publisher:** Wolters Kluwer Health, Inc. for AASLD (American Association for the Study of Liver Diseases)
- **ISSN:** 2471-254X (online-only, fully open access)
- **Homepage:** https://journals.lww.com/hepcomm
- **Author guidelines:** https://edmgr.ovid.com/hepcomm/accounts/ifauth.htm
- **Submission portal:** https://mc.manuscriptcentral.com/hepcomm

## Scope
Hepatology Communications is the AASLD-published, peer-reviewed, online-only, fully open-access companion to Hepatology, dedicated to fast dissemination of high-quality basic, translational, and clinical research in hepatology. Authors retain copyright; articles are immediately and freely available to read and share.

## Scope Keywords
hepatology, liver disease, MASLD, NAFLD, MASH, NASH, MetALD, ALD, alcohol-associated liver disease, chronic hepatitis B, chronic hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, liver transplantation, basic hepatology, translational hepatology, clinical hepatology, MASLD nomenclature

## Article Types Accepted
- Original Research Article (≤ 5,000 words; abstract 275 words; ≤ 50 references; ≤ 8 figures/tables)
- Review (≤ 5,000 words, invited preferred)
- Editorial (≤ 1,500 words; invited; "Viewpoints" unsolicited considered)
- Research Letter (≤ 1,000 words; clinical research only; no abstract; ≤ 10 refs; ≤ 1 table or figure)
- Correspondence (500–750 words)
- Special Articles (AASLD practice guidelines, in-depth reviews, social policy ≤ 5,000 words)
- Protocol Paper (pre-registered ongoing trials/studies; ≤ 5,000 words)
- Consensus Report (≤ 2,000 words; ≤ 9 refs)

## Classification
- **Tier:** Q1 hepatology (AASLD family)
- **Open Access:** Full OA, mandatory CC BY or CC BY-NC-ND license
- **Field:** hepatology — basic, translational, clinical

## Special Notes
AASLD's open-access companion to Hepatology — receives transferred submissions from Hepatology and other AASLD/Wiley liver journals, often with prior peer-review portable. Mandates the 2023 MASLD/MASH revised nomenclature in submitted manuscripts unless explicitly justified ("Manuscripts ... should employ this revised terminology wherever scientifically appropriate"). PaperPal Preflight pre-submission check available. STROBE checklist mandatory for cohort/cross-sectional studies. AI policy follows ICMJE: AI use must be disclosed in Materials and Methods AND cover letter, AI cannot be author, AI-generated text/images must be reviewed for accuracy by author who takes full responsibility. Initial submission allowed in single Word file with no strict formatting; revisions must use 1.5-spaced 10–12 pt body.

## Article Processing Charges (verified from PDF, 2025 rates)
- Tier 1 (Articles, Reviews, Experimental Research): AASLD member US$1,890 / non-member US$3,150
- Tier 2 (Letters, Editorials, Correspondence): AASLD member US$480 / non-member US$800

## Acceptance Rate (estimated)
~30–35 % (AASLD/Wiley OA companion typically more accepting than parent Hepatology; PubsHub editor reports 2024).

# Hepatology International

## Identity
- **Abbreviation:** Hepatol Int
- **Publisher:** Springer Nature on behalf of APASL (Asian Pacific Association for the Study of the Liver)
- **ISSN:** 1936-0533 / 1936-0541
- **Homepage:** https://link.springer.com/journal/12072
- **Author guidelines:** https://link.springer.com/journal/12072/submission-guidelines
- **Editorial Manager:** https://www.editorialmanager.com/heip

## Scope
Hepatology International is the official journal of APASL, publishing original basic, translational, and clinical research in hepatology with strong representation of Asia-Pacific cohorts and disease patterns. Particularly prominent for MASLD/NAFLD natural history in East-Asian populations, chronic hepatitis B (regional endemic), HCC surveillance, and APASL-aligned guideline-relevant work.

## Scope Keywords
hepatology, liver disease, MASLD, NAFLD, lean MASLD, MetALD, ALD, chronic hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, APASL guidelines, Asia-Pacific cohort, Asian liver disease, ACLF, acute-on-chronic liver failure, liver transplantation, biomarkers

## Article Types Accepted
- **Original Article** (≤ 4,000 words including references; abstract 250 words structured; 10 keywords; **graphical abstract MANDATORY**; ≤ 30 references; ≤ 6 tables/figures combined)
- Review Article (≤ 5,000 words; abstract 250 words; ≤ 100 refs; ≥ 4 colored figures and ≥ 4 tables MANDATORY; total up to 8 illustrations)
- Mini Review (≤ 2,500 words excluding refs; abstract 150 words; ≤ 30 refs; ≥ 2 figures recommended; total up to 4 illustrations)
- Invited Article / Editorial (by invitation only; ≤ 1,500 words; ≤ 10 refs; 1 figure)
- Consensus Report (≤ 2,000 words; ≤ 9 refs)
- Letter to Editor (≤ 500 words; ≤ 5 refs; 1 figure)
- Point-of-View (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 2 figures)
- Commentary (by invitation; ≤ 1,500 words; ≤ 10 refs; 1 table + 1 figure)
- Multimedia / Dynamic Articles (with embedded video supplements ≤ 9 min)

## Classification
- **Tier:** Q1 hepatology (APASL flagship)
- **Open Access:** Hybrid (OA optional via Springer's Open Choice; APC ~US$3,090 for OA)
- **Field:** hepatology — clinical and translational, Asia-Pacific emphasis

## Special Notes
Copyright on accepted manuscripts is held by APASL (mandatory Copyright/Authorship/Disclosure Form signed by all authors at submission). Original Articles must include a single-panel graphical abstract (300 dpi+, .tif/.jpg, Arial 12–16 pt, RGB) placed next to abstract — labelled "Graphical Abstract" — this is one of the journal's strictest unique requirements. STROBE for cohort studies, PRISMA for SR/MA, STARD for diagnostic accuracy, ARRIVE for animals are required to be cited and uploaded as supplemental. Compliance with Ethical Requirements section (CoI / informed consent / human-and-animal-rights) goes on the title page only. Strong fit for Korean cohort epidemiology — sister society KASL is a long-standing APASL member, and Korean MASLD natural-history papers are well represented in recent volumes.

## Acceptance Rate (estimated)
~25–30 % (Springer/APASL editor reports; Hepatol Int sits between CMH (KASL) and parent Hepatology in selectivity).

# IEEE Journal of Biomedical and Health Informatics

## Identity
- **Abbreviation:** IEEE J Biomed Health Inform, IEEE JBHI
- **Publisher:** IEEE (Institute of Electrical and Electronics Engineers)
- **ISSN:** 2168-2194 / 2168-2208
- **Homepage:** https://www.embs.org/jbhi/
- **Author guidelines:** https://www.embs.org/jbhi/author-information/

## Scope
IEEE JBHI publishes research on information technology and its application to biomedical and health data. Coverage spans biomedical signal processing, wearable sensors, health monitoring, medical image analysis, bioinformatics, telemedicine, and AI-driven clinical decision support. The journal bridges electrical engineering, computer science, and health sciences.

## Scope Keywords
biomedical signal processing, wearable sensors, health monitoring, ECG analysis, EEG analysis, medical image analysis, deep learning healthcare, IoT health, telemedicine, bioinformatics, clinical decision support, federated learning, edge computing health, physiological signals, health informatics

## Article Types Accepted
- Regular Paper
- Short Paper
- Survey Paper
- Correspondence

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (IEEE Open Access option)
- **Field:** Biomedical engineering / Health informatics

## Special Notes
IEEE JBHI is one of the top IEEE journals for health-related AI and engineering research. It values technical depth in signal processing, systems engineering, and algorithm design alongside clinical relevance. The journal is strong in wearable/sensor-based health AI, federated learning for healthcare, and multimodal health data fusion. IEEE formatting and citation style required.

# IEEE Transactions on Medical Imaging

## Identity
- **Abbreviation:** IEEE Trans Med Imaging
- **Publisher:** IEEE (Institute of Electrical and Electronics Engineers)
- **ISSN:** 0278-0062 / 1558-254X
- **Homepage:** https://ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=42
- **Author guidelines:** https://www.embs.org/tmi/authors/

## Scope
IEEE Transactions on Medical Imaging publishes original research on the formation, processing, and analysis of medical images. Coverage includes imaging physics, reconstruction algorithms, image segmentation, registration, detection, classification, and computer-aided diagnosis across all modalities (CT, MRI, PET, ultrasound, X-ray, microscopy, pathology). Emphasis is on algorithmic novelty and mathematical rigor with validation on medical imaging data.

## Scope Keywords
medical imaging, image reconstruction, image segmentation, image registration, deep learning, convolutional neural networks, computed tomography, magnetic resonance imaging, ultrasound, pathology, computer-aided detection, object detection, image classification, self-supervised learning, transformer, generative models, physics-informed networks, federated learning

## Article Types Accepted
- Regular Paper (12 pages, IEEE 2-column)
- Short Paper (6 pages)
- Correspondence (3 pages)
- Special Issue Papers

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (IEEE OA option)
- **Field:** Medical imaging / Biomedical engineering

## Special Notes
IEEE TMI uses strict page limits (12 pages including figures, tables, and references in IEEE 2-column format) rather than word limits. LaTeX with IEEEtran class is standard. The journal frequently publishes extended versions of MICCAI/ISBI conference papers (requiring 30%+ new content). Technical novelty in imaging methodology is required; clinical application alone without algorithmic contribution is insufficient. Papers typically include ablation studies, comparison with state-of-the-art, and computational cost analysis.

# Interventional Neuroradiology

## Identity
- **Abbreviation:** Interv Neuroradiol
- **Publisher:** SAGE Publications (ESMINT / WFITN)
- **ISSN:** 1591-0199 / 2385-2011
- **Homepage:** https://journals.sagepub.com/home/INI
- **Author guidelines:** https://journals.sagepub.com/author-instructions/INI

## Scope
Interventional Neuroradiology publishes original research, reviews, and case reports on endovascular and minimally invasive neuroradiology, including cerebrovascular interventions, mechanical thrombectomy, aneurysm treatment, AVM embolization, and novel neurovascular devices.

## Scope Keywords
neurointerventional radiology, mechanical thrombectomy, cerebral aneurysm, flow diversion, coiling, AVM embolization, dural arteriovenous fistula, carotid stenting, intracranial atherosclerosis, stroke intervention, venous sinus stenting, tumor embolization, spinal vascular intervention, neurovascular devices, endovascular treatment

## Article Types Accepted
- Original Article
- Review Article
- Technical Note
- Case Report
- Letter to the Editor

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (SAGE Choice)
- **Field:** Interventional neuroradiology

## Special Notes
Interventional Neuroradiology is the official journal of ESMINT and WFITN, dedicated exclusively to minimally invasive neurovascular procedures. Accepts smaller case series (N=5-20) for novel techniques as technical notes. Requires explicit reporting of all complications including minor ones. Choose INSI over AJNR when the study is purely about interventional technique, devices, or endovascular outcomes. AI policy: follows ICMJE — disclose AI use in Methods.

# Investigative Radiology

## Identity
- **Abbreviation:** Invest Radiol
- **Publisher:** Wolters Kluwer / Lippincott Williams & Wilkins
- **ISSN:** 0020-9996 / 1536-0210
- **Homepage:** https://journals.lww.com/investigativeradiology/
- **Author guidelines:** https://journals.lww.com/investigativeradiology/pages/informationforauthors.aspx

## Scope
Investigative Radiology publishes original research on novel imaging techniques, contrast agents, imaging physics, and translational imaging science, emphasizing early and timely publication of diagnostic imaging advances with high methodological rigor.

## Scope Keywords
contrast agents, imaging physics, MRI techniques, CT technology, molecular imaging, quantitative imaging, imaging biomarkers, diffusion imaging, perfusion imaging, spectroscopy, photon-counting CT, dual-energy CT, ultrafast MRI, translational imaging, preclinical imaging, gadolinium

## Article Types Accepted
- Original Research

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (CC BY-NC-ND)
- **Field:** Radiology / Imaging science

## Special Notes
Investigative Radiology is a highly selective journal focused on imaging science and technology rather than clinical case series. It does not accept case reports, reviews, or technical notes — only original research. Known for rapid publication of novel contrast agent studies and imaging physics advances. AI policy: AI use discouraged, must disclose in cover letter and Acknowledgments.

## Acceptance Signals
- **Selectivity band:** highly-selective
- **Desk-reject triggers:** clinical case series; case reports, reviews, or technical notes (not accepted — original research only); work without a methodologically novel imaging-science contribution
- **Design expectations:** high methodological rigor; a novel imaging technique, contrast agent, or physics advance
- **Study-type tolerance:** original research only
- **Review process:** AI use discouraged — disclose in cover letter and Acknowledgments
- **Cascade / transfer:** tier-down to a general radiology or applied-imaging journal for clinically oriented work

# JACC: Advances

## Identity
- **Abbreviation:** JACC Adv
- **Publisher:** Elsevier (on behalf of the American College of Cardiology)
- **ISSN:** 2772-963X (online; full open access)
- **Homepage:** https://www.sciencedirect.com/journal/jacc-advances
- **Author guidelines:** https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors

## Scope
JACC: Advances provides a global forum for clinical research articles and timely reviews focused on advances in cardiovascular medicine. Content areas include arrhythmia and electrophysiology, cardio-obstetrics, cardiovascular surgery, congenital heart disease, coronary heart disease, critical care cardiology, digital health, genetics, geriatric cardiology, global health, health services research, heart failure, imaging, interventional cardiology, and other cardiovascular fields. The journal strives to appeal to authors across the spectrum of the cardiovascular care team at every career stage and considers original research articles, including applied clinical, epidemiological, and health care policy papers related to cardiovascular and cerebrovascular diseases.

## Scope Keywords
cardiovascular medicine, cardiovascular research, epidemiology, prevention, cardio-metabolic, cardiovascular-kidney-metabolic, CKM staging, coronary artery calcium, cardiac CT, atherosclerosis, heart failure, hypertension, diabetes, dyslipidemia, screening cohort, observational study, health services research, digital health, global cardiology

## Article Types Accepted
- Original Research Papers
- State-of-the-Art Reviews
- Methodology Corner
- Brief Reports
- Research Letters
- Viewpoints
- Letters to the Editor (and Replies)
- Editorial Comments
- JACC: Advances Expert Panel

## Classification
- **Tier:** Emerging Q1 (JACC family, full open access)
- **Open Access:** Full Gold OA — APC USD 3,024 (Original Research / Reviews / Methodology / Expert Panel); USD 1,300 (Research Letters / Brief Reports). 10% discount for ACC members and early-career authors (≤10 years post-training); 50% discount for authors from developing countries.
- **Field:** Cardiovascular medicine — broad

## Special Notes
Editor-in-Chief Candice K. Silversides, MD (University Health Network, University of Toronto). Original Research is capped at **5,000 words** (including text, references, and figure legends) with a **structured 250-word abstract using Background / Objectives / Methods / Results / Conclusions**. State-of-the-Art Reviews and Expert Panels permit ≤10,000 words with an unstructured 150-word abstract; Brief Reports ≤1,200 words and Research Letters ≤1,000 words, each capped at 1 simple figure/table. References use **Vancouver superscript numerals** with "list all authors if 6 or fewer, otherwise list the first 3 and add et al." (journal titles italicized). The Guide for Authors does not display a journal-specific AI policy; Elsevier publisher-level policy applies — AI cannot be listed as an author, AI use in writing must be disclosed in a dedicated declaration immediately before the references, and AI may not be used to create or alter images. Submission portal: https://www.jaccsubmit-advances.org. As of 2026-05 the journal is not yet indexed for an Impact Factor (Web of Science indexing pending) — use it for novel framework applications where AHA-aligned editorial assessment is helpful and a global open-access audience matters more than IF.


---

## Verification
- **Source:** https://www.sciencedirect.com/journal/jacc-advances/publish/guide-for-authors
- **Date (harvested from a local profile library):** 2026-05
- **Date (promoted to public):** 2026-05-21

# JACC: Asia

## Identity
- **Abbreviation:** JACC Asia
- **Publisher:** Elsevier (American College of Cardiology)
- **ISSN:** 2772-3747 (online)
- **Homepage:** https://www.jacc.org/journal/jacc-asia
- **Author guidelines:** https://www.sciencedirect.com/journal/jacc-asia/publish/guide-for-authors

## Scope
JACC: Asia is the open-access sister journal in the JACC family devoted to cardiovascular research relevant to Asian populations and Asian healthcare systems. It publishes original investigations, state-of-the-art reviews, and clinical commentaries on epidemiology, prevention, imaging, interventional cardiology, electrophysiology, heart failure, and structural heart disease, with priority for Asian-data-driven evidence and Asia-Pacific clinical practice.

## Scope Keywords
cardiovascular medicine, Asia-Pacific cardiology, coronary artery disease, coronary calcium, cardiac CT, cardiac MRI, atherosclerosis, heart failure, atrial fibrillation, hypertension, dyslipidemia, diabetes, MASLD, cardio-metabolic, structural heart disease, valvular heart disease, interventional cardiology, electrophysiology, prevention, Asian epidemiology, health screening

## Article Types Accepted
- Original Investigation (Original Research)
- State-of-the-Art Review
- Mini-Focus / Special Series
- Research Letter
- Editorial / Viewpoint (invited)
- Letter to the Editor

## Classification
- **Tier:** Emerging Q1 (JACC family; SCI indexing expected 2027, anticipated IF ~5–6)
- **Open Access:** Full Gold OA
- **Field:** Cardiovascular medicine — Asia-Pacific focus

## Special Notes
JACC: Asia is the youngest member of the JACC family (launched 2021) and is positioned as the regional flagship for Asian cardiovascular evidence; Asian-data specificity, regional generalizability, and policy relevance to Asia-Pacific healthcare systems are explicitly weighed in editorial assessment. Original Investigations are capped at 5,000 words including text, references, and figure legends combined, with a 250-word structured abstract (Background/Objectives/Methods/Results/Conclusions). References use Vancouver superscript, list first 3 authors plus et al., and use Index Medicus abbreviations. AI policy: follows Elsevier/ICMJE — language editing only, must be disclosed in both the cover letter and the Acknowledgments, AI cannot be listed as author, and AI-generated images are not permitted unless explicitly declared.

# Journal of the American College of Radiology

## Identity
- **Abbreviation:** J Am Coll Radiol
- **Publisher:** Elsevier (American College of Radiology)
- **ISSN:** 1546-1440 / 1558-349X
- **Homepage:** https://www.jacr.org/
- **Author guidelines:** https://www.jacr.org/content/authorinfo

## Scope
JACR publishes original research, opinions, and policy papers in five domains: health services research/policy, clinical practice management, data science, training/education, and leadership, focusing on how radiology is practiced, managed, and improved at the systems level.

## Scope Keywords
health services research, radiology policy, imaging utilization, practice management, radiology workforce, value-based imaging, appropriateness criteria, clinical decision support, radiology education, quality metrics, patient safety, AI implementation, healthcare economics, radiology leadership, data science

## Article Types Accepted
- Original Article
- Brief Report (invited only)
- Opinion
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Radiology / Health policy / Practice management

## Special Notes
JACR is the official journal of the American College of Radiology, uniquely positioned at the intersection of radiology and health policy. Does not publish clinical reviews, book reviews, or case reports. Strict author limits (Original Article <= 7 authors). Requires a Summary Sentence (<35 words) and Take Home Points (3-6 bullets) instead of a traditional Conclusions section. AI policy: language editing only, must disclose use, AI cannot be listed as author.

# JAMA

## Identity
- **Abbreviation:** JAMA
- **Publisher:** American Medical Association
- **ISSN:** 0098-7484 / 1538-3598
- **Homepage:** https://jamanetwork.com/journals/jama
- **Author guidelines:** https://jamanetwork.com/journals/jama/pages/instructions-for-authors

## Scope
JAMA publishes original research, reviews, and opinion across all fields of medicine. It emphasizes studies with broad clinical relevance, public health implications, and policy impact. The journal values rigorous methodology, large-scale studies, and findings that inform clinical decision-making or health care delivery.

## Scope Keywords
clinical research, public health, health policy, randomized controlled trial, epidemiology, clinical outcomes, therapeutics, preventive medicine, health equity, evidence-based medicine, screening, diagnosis, treatment, global health, medical education

## Article Types Accepted
- Original Investigation
- Research Letter
- Review
- Clinical Review and Education
- Viewpoint
- Editorial
- Preliminary Communication
- Special Communication
- JAMA Diagnostic Test Interpretation

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (optional OA)
- **Field:** General medicine

## Special Notes
JAMA and JAMA Network journals (JAMA Internal Medicine, JAMA Surgery, JAMA Network Open, etc.) share a submission system. If rejected from JAMA, authors can transfer to a JAMA Network specialty journal. JAMA has a strong statistical review process and values structured reporting. Diagnostic accuracy studies and AI papers are considered if they demonstrate clear clinical utility.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Language editing only
- **Disclosure location:** Methods + Cover letter
- **AI-generated images:** Not specified — disclosure required if used
- **Policy URL:** https://jamanetwork.com/journals/jama/pages/instructions-for-authors#702720037

# JAMA Network Open

## Identity
- **Abbreviation:** JAMA Netw Open
- **Publisher:** American Medical Association (AMA)
- **ISSN:** 2574-3805
- **Homepage:** https://jamanetwork.com/journals/jamanetworkopen
- **Author guidelines:** https://jamanetwork.com/journals/jamanetworkopen/pages/instructions-for-authors

## Scope
JAMA Network Open is a fully open access, multidisciplinary journal publishing original research across all areas of medicine, including clinical care, innovation in health care, and global health. It publishes studies that advance medical knowledge, improve clinical practice, or inform health policy, accepting a broader range of study designs and sample sizes than JAMA.

## Scope Keywords
clinical research, observational studies, randomized trials, health outcomes, health services research, global health, public health, epidemiology, medical AI, diagnostic accuracy, quality improvement, patient safety, disparities, digital health, cohort study

## Article Types Accepted
- Original Investigation
- Research Letter
- Invited Commentary
- Systematic Review and Meta-Analysis
- Diagnostic/Prognostic Study
- US Preventive Services Task Force

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (APC ~$3,500)
- **Field:** General medicine (multidisciplinary)

## Special Notes
JAMA Network Open is the most accessible high-impact general medical journal for original research. It accepts studies across all specialties including AI/radiology with clinical endpoints, diagnostic accuracy studies, and meta-analyses. Shares JAMA's structured abstract (7-heading) and Key Points box requirements. APC waiver available for LMIC authors. Acceptance rate ~15-20%. AI policy: language editing only, Methods + cover letter disclosure required per JAMA Network policy.

# Journal of the American Society of Nephrology

## Identity
- **Abbreviation:** J Am Soc Nephrol
- **Publisher:** Wolters Kluwer (ASN)
- **ISSN:** 1046-6673 / 1533-3450
- **Homepage:** https://journals.lww.com/jasn
- **Author guidelines:** https://journals.lww.com/jasn/Pages/instructionsforauthors.aspx

## Scope
JASN is the premier flagship journal in nephrology, publishing highly novel, practice-changing research spanning basic organ physiology, disease pathology, clinical trials, and epidemiology. It prioritizes work of wide interest to the global nephrology community.

## Scope Keywords
nephrology, glomerulonephritis, acute kidney injury, chronic kidney disease, diabetic kidney disease, hemodialysis, peritoneal dialysis, kidney transplantation, podocyte, tubule, electrolyte disorders, mineral bone disorder, hypertension, renin-angiotensin system, clinical trials, genetic kidney disease

## Article Types Accepted
- Original Article
- Brief Communication
- Review
- Clinical Practice Points
- Editorial

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Nephrology (general, flagship)

## Special Notes
JASN (IF ~12.7) is highly selective (~10% acceptance rate). Requires a separate Significance Statement (≤120 words) written for a general audience. Strictly limits display items to 8 combined figures/tables. AI policy: language editing only, disclose in Methods/Acknowledgments, AI images banned.

## Verification
- **Source:** JASN Instructions to Authors, read during maintainer review of PR #330 — verification record: https://github.com/Aperivue/medsci-skills/pull/330#issuecomment-4968075916
- **Date:** 2026-07-14
- **Note:** the 3,000-word body ("excluding methods, references, figure legends, and tables"), the ≤120-word Significance Statement and the 8-display-item cap were each confirmed against the journal's own instructions. A direct URL is not recorded here because none was captured at the time and the publisher blocks automated retrieval; supplying one now would be a guess, not a citation. Replace this with the canonical instructions URL when someone next opens it.

# Journal of Cachexia, Sarcopenia and Muscle

## Identity
- **Abbreviation:** J Cachexia Sarcopenia Muscle (JCSM)
- **Publisher:** Wiley
- **ISSN:** [TODO: verify at JCSM journal page]
- **Homepage:** https://onlinelibrary.wiley.com/journal/13989440
- **Author guidelines:** https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
- **Submission portal:** https://authors.wiley.com/journal/JCSM/

## Scope
The Journal of Cachexia, Sarcopenia and Muscle is the dedicated international journal for cachexia, sarcopenia, body composition, and skeletal-muscle and adipose-tissue physiology/pathophysiology across the lifespan and across chronic diseases (cancer, heart failure, lung disease, cirrhosis, kidney failure, rheumatoid arthritis, sepsis, AIDS). The journal serves researchers and clinicians studying muscle wasting, lipolysis, sarcopenic obesity, ageing-related body composition changes, and prognostic/diagnostic biomarkers for these conditions.

## Scope Keywords
cachexia, sarcopenia, sarcopenic obesity, body composition, skeletal muscle, muscle wasting, adipose tissue, lipolysis, ageing, frailty, chronic disease, cancer cachexia, heart failure cachexia, COPD muscle wasting, cirrhosis sarcopenia, kidney failure cachexia, prognostic markers, body composition imaging, bioelectrical impedance, DXA, CT body composition, muscle biomarkers

## Article Types Accepted
- Original Article (4,500 words, abstract 400 structured data-rich, refs 40, ≤8 figures/tables with max 6 sub-sections per figure)
- Review (6,000 words, abstract 400 unstructured data-rich, refs 120)
- Editorial (invited only; 1,500 words; Facts & Numbers series allows abstract up to 400 words)
- Research/Scientific Letter (1,200 words, 1 figure/table, 10 refs)
- Short Report (1,500 words, ≤2 figures/tables, 10 refs)
- Meeting Report (1,500 words, 20 refs)
- Reply / Letter to the Editor (1,200 words)

## Classification
- **Tier:** Q1 (specialty journal — dedicated to cachexia/sarcopenia/body composition)
- **Open Access:** Gold OA, APC required on acceptance (waivers/discounts may apply)
- **Field:** Cachexia / Sarcopenia / Body Composition / Skeletal Muscle / Adipose Tissue

## Special Notes
JCSM is the dedicated international journal for cachexia, sarcopenia, and body composition research, published by Wiley under Gold Open Access (APC required on acceptance). **Single-blind peer review.** Continuous publication model (articles publish to online issue when ready; no issue pagination delay). Title cap ≤17 words / 120 characters. **Abstract must be data-rich (≤400 words, structured: Background/Methods/Results/Conclusions) with actual numbers, effect sizes, hazard ratios, 95% CIs, and p-values — "descriptive results abstracts are not acceptable."** Original Article body ≤4,500 words; 40 references in main + unlimited supplement (S1, S2, ...). **Only ONE corresponding author per submission**; multiple co-first or equal-contribution requests must be declared in cover letter. **For survival/prognostic studies, JCSM enforces strict reporting**: 1-year mortality rate with 95% CI (plus 5-year and/or 3-month as appropriate) in both abstract AND methods/results; Kaplan-Meier plots with "patients at risk" annotation at baseline + follow-up intervals; novel prognostic markers expected from cohorts with ≥60–100 events, novel prognostic scores ≥150–200 events. Validation in second cohort strongly recommended. Reference style flexible (since August 2024) but must be consistent and complete (author, year, journal/book, article title, volume, pages, DOI optional). Preprints permitted (declare server + accession/DOI in cover letter). AI policy: [TODO: verify at journal AI policy page] — Wiley publisher-wide policy generally requires disclosure of AI tools and bars AI as author.


---

## Verification
- **Source:** https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
- **Date:** 2026-05-21

# Journal of Korean Medical Science

## Identity
- **Abbreviation:** J Korean Med Sci
- **Publisher:** Korean Academy of Medical Sciences (KAMS)
- **ISSN:** 1011-8934 (print) / 1598-6357 (electronic)
- **Homepage:** https://jkms.org
- **Author guidelines:** https://jkms.org (Author Information section)
- **Submission portal:** https://submit.jkms.org

## Scope
JKMS publishes original research, reviews, case reports, and editorials across all medical specialties — clinical, basic-science, public-health, and epidemiology. The journal is the leading generalist English-language medical journal published by the Korean Academy of Medical Sciences with broad receptivity to Korean and East Asian population studies, single-institution observational research, and cross-disciplinary work with clear clinical implications.

## Scope Keywords
general medicine, Korean population, East Asian medicine, clinical epidemiology, public health, observational cohort, retrospective cohort, single-institution study, IRB-approved retrospective study, cross-disciplinary medicine, MD-MD-research

## Article Types Accepted
- Original Article (3,000 words, 6 figures)
- Review Article (invited, ≤6 figures)
- Brief Communication (1,500 words, 3 figures)
- Case Report (1,500 words, 4 figures)
- Case Conference for CME (2,500 words, 6 figures)
- Editorial / Opinion / Guideline (600–1,500 words)
- Correspondence (600 words, 1 figure)

## Classification
- **Tier:** Q1 (generalist medical journal)
- **Open Access:** Full OA, indexed in PubMed/MEDLINE, SCIE, Scopus
- **Field:** General Medicine

## Special Notes
JKMS is the flagship English-language generalist medical journal published by the Korean Academy of Medical Sciences, weekly online-only. References use Vancouver format with EndNote `jkms.ens` provided. Strict 3,000-word limit for original articles (Methods + Results + Discussion + Conclusion); abstract structured to 350 words (Background-Methods-Results-Conclusion). Submission requires title-page docx, main-body docx, tables/figures separate uploads, cover letter (addressed to EIC), per-author ICMJE COI, CRediT contributor declarations, and Data Availability Statement. APC charged on acceptance. AI policy follows ICMJE: disclose AI use in cover letter; AI cannot be listed as author. Typical review timeline ~8 weeks. Particularly receptive to Korean cohort studies with broad medical relevance and to single-institution observational work with clear clinical implications.

# Journal of Medical Internet Research

## Identity
- **Abbreviation:** J Med Internet Res
- **Publisher:** JMIR Publications
- **ISSN:** 1438-8871 (online only)
- **Homepage:** https://www.jmir.org/
- **Author guidelines:** https://www.jmir.org/author-instructions

## Scope
Flagship journal of JMIR Publications covering digital health, health informatics, and emerging technologies applied to healthcare delivery. ML papers accepted only with direct clinical impact and independent validation. Pure clinical informatics without patient/consumer empowerment angle is routed to sister journals.

## Scope Keywords
digital health, mHealth, telemedicine, health informatics, eHealth, wearable devices, patient engagement, clinical decision support, health apps, internet intervention, remote monitoring, online health communities, digital therapeutics, artificial intelligence in health, consumer health informatics, virtual care

## Article Types Accepted
- Original Paper
- Digital Health Review
- Viewpoint/Perspective
- Research Letter
- Policy Paper

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (Gold)
- **Field:** Digital health / Health informatics

## Special Notes
Ranked #1 in Medical Informatics by Google Scholar; highly selective with cascading peer review to JMIR sister journals. Fast-track option available (4-week turnaround). No bare URLs in body text — all must be cited as references. AI policy: follows ICMJE — disclose AI use in Methods.

# JMIR Medical Education

## Identity
- **Abbreviation:** JMIR Med Educ
- **Publisher:** JMIR Publications
- **ISSN:** 2369-3762 (online only)
- **Homepage:** https://mededu.jmir.org/
- **Author guidelines:** https://mededu.jmir.org/author-instructions

## Scope
Covers digital technology in medical and health professions education, including e-learning, simulation, AI-assisted teaching, virtual reality training, and online assessment. Bridges health informatics and education research with emphasis on technology-mediated learning innovations.

## Scope Keywords
medical education technology, e-learning, simulation-based education, virtual reality training, artificial intelligence in education, online assessment, gamification, digital literacy, learning analytics, mobile learning, telemedicine education, virtual patients, augmented reality, large language models in education, competency-based digital education

## Article Types Accepted
- Original Paper
- Review
- Viewpoint
- Policy Paper
- Students' Corner

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (CC BY 4.0)
- **Field:** Medical education technology

## Special Notes
High-impact (IF ~12.6) JMIR sister journal focused on technology-enhanced medical education. Cascading peer review from JMIR flagship; single-blind with named reviewers published alongside accepted articles. Fast-track option (20 working days). AI policy: generative AI use must be disclosed per JMIR AI policy.

# Journal of NeuroInterventional Surgery

## Identity
- **Abbreviation:** J NeuroIntervent Surg (JNIS)
- **Publisher:** BMJ Publishing Group / Society of NeuroInterventional Surgery (SNIS)
- **ISSN:** 1759-8478 (print) / 1759-8486 (online)
- **Homepage:** https://jnis.bmj.com
- **Author guidelines:** https://jnis.bmj.com/pages/authors/

## Scope
JNIS publishes original research, reviews, and case material on endovascular and surgical neurointervention — acute ischemic stroke thrombectomy, intracranial aneurysm coiling and flow diversion, AVM and dAVF embolization, carotid and intracranial stenting, spine interventions, and emerging neurointerventional devices and techniques. The journal is the official journal of the Society of NeuroInterventional Surgery (SNIS) and partners with several international neurointerventional societies.

## Scope Keywords
mechanical thrombectomy, intracranial aneurysm, flow diverter, coil embolization, arteriovenous malformation, dural arteriovenous fistula, carotid stenting, acute ischemic stroke intervention, endovascular treatment, neurointerventional device, stroke imaging, clot analysis, angiography, intracranial atherosclerosis

## Article Types Accepted
- Original Research
- Review
- Case Series
- Brief Report
- Short Report
- Case Report (brief format)
- Technical Note / New Device
- Socioeconomics
- Editorial / Commentary
- Letter to the Editor / e-Letter
- Video Report

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (optional Gold OA with APC; standard subscription route free to authors)
- **Field:** Neurointervention / endovascular neurosurgery / interventional neuroradiology

## Special Notes
Official journal of SNIS. Peer review is double-anonymised — author identities removed from the manuscript file. ORCID iD is mandatory for the submitting author. Original Research requires a structured 250-word abstract and a "Key messages" summary box with three bullets (What is already known / What this study adds / How this study might affect research, practice or policy). Follows BMJ Tier 3 data-sharing policy: a Data Availability Statement is mandatory for all research articles. Reporting guideline adherence is required (STROBE/CONSORT/PRISMA/STARD/ARRIVE as applicable) and the completed checklist must be uploaded. Acceptance rate approximately 18% with a median first decision around 24 days (BMJ metrics, verify at submission). AI policy follows BMJ/ICMJE: generative AI cannot be listed as an author; any substantive use must be disclosed in Methods and/or Acknowledgments; AI-generated or -manipulated images are not permitted.

# Journal of Biomedical Informatics

## Identity
- **Abbreviation:** J Biomed Inform, JBI
- **Publisher:** Elsevier
- **ISSN:** 1532-0464 / 1532-0480
- **Homepage:** https://www.sciencedirect.com/journal/journal-of-biomedical-informatics
- **Author guidelines:** https://www.elsevier.com/journals/journal-of-biomedical-informatics/1532-0464/guide-for-authors

## Scope
Journal of Biomedical Informatics publishes research on computational and informatics methods applied to biomedical data. Coverage includes clinical informatics, health information systems, electronic health records, clinical NLP, knowledge representation, decision support systems, and data science applied to health data. It bridges computer science and clinical medicine through information technology.

## Scope Keywords
biomedical informatics, clinical informatics, electronic health records, clinical decision support, natural language processing, health data science, knowledge representation, ontology, phenotyping, clinical NLP, EHR, prediction models, machine learning clinical data, patient outcomes, data integration

## Article Types Accepted
- Original Research
- Review Article
- Methodological Review
- Short Communication
- Special Communication

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Medical informatics

## Special Notes
JBI is distinguished from image-focused AI journals by its emphasis on structured clinical data (EHR, claims, lab results) rather than imaging data. It values methodological rigor and clinical applicability. Studies on large language models for clinical NLP, clinical prediction models, and health information exchange are well-suited. The journal requires clear description of data provenance and clinical context.

# The Journal of Clinical Endocrinology & Metabolism (JCEM)

## Identity
- **Abbreviation:** J Clin Endocrinol Metab
- **Publisher:** Oxford University Press (on behalf of the Endocrine Society)
- **ISSN:** 0021-972X (print) / 1945-7197 (online)
- **Homepage:** https://academic.oup.com/jcem
- **Author guidelines:** https://academic.oup.com/jcem/pages/Author_Guidelines

## Scope
JCEM positions itself as "the world's leading peer-reviewed journal for endocrine clinical research and clinical practice." Article types span original research, reviews, case reports, commentaries, and consensus statements covering endocrinology, metabolism, diabetes, thyroid, bone, reproductive endocrinology, and adrenal/pituitary disease.

## Scope Keywords
clinical endocrinology, metabolism, diabetes, thyroid, bone disease, reproductive endocrinology, adrenal disease, pituitary disease, metabolic syndrome, insulin resistance, cardio-metabolic, obesity, lipid metabolism, cardiovascular-kidney-metabolic, CKM staging

## Article Types Accepted
- Clinical Research Article (Original)
- Approach to the Patient
- Mini-review
- Meta-analysis
- Editorial
- Commentary
- Letter to the Editor
- Report and Recommendation (society/consensus)

## Classification
- **Tier:** Q1 (Endocrine Society flagship)
- **Open Access:** Hybrid — page charge model (USD 99–119 per PDF page member/non-member; color figure surcharge USD 235–735); open access option separate via OUP open-access portal
- **Field:** Clinical endocrinology and metabolism

## Special Notes
Editor-in-Chief Paul M. Stewart, MD. Original Articles do not have a stated upper word limit (Approach to the Patient 2,000–5,000 words; Mini-reviews 2,000–5,000 words). Required **250-word structured abstract describing purpose, methods, results, and main conclusions in complete sentences without direct text references**. References use **AMA citation style with consecutive numerical ordering** and the guideline states "List all authors for the initial submission" (no first-N-then-et-al truncation at submission stage). AI policy (verbatim): "The use of artificial intelligence (AI) tools must be disclosed during the submission process and also described in the Methods or Acknowledgments sections of the text." Reviewers are explicitly prohibited from uploading any part of a manuscript into LLM tools during review. Submission portal: https://www.editorialmanager.com/jcem/. Choose JCEM when the metabolic-syndrome / insulin-resistance / cardio-metabolic mechanism is the primary scientific contribution and cardiovascular outcomes serve a supporting role (rather than the inverse).


---

## Verification
- **Source:** https://academic.oup.com/jcem/pages/Author_Guidelines
- **Date (harvested from a local profile library):** 2026-05
- **Date (promoted to public):** 2026-05-21

# Journal of Magnetic Resonance Imaging

## Identity
- **Abbreviation:** JMRI, J Magn Reson Imaging
- **Publisher:** Wiley (International Society for Magnetic Resonance in Medicine)
- **ISSN:** 1053-1807 / 1522-2586
- **Homepage:** https://onlinelibrary.wiley.com/journal/15222586
- **Author guidelines:** https://onlinelibrary.wiley.com/page/journal/15222586/homepage/forauthors.html

## Scope
JMRI publishes original research on all aspects of magnetic resonance imaging in medicine, including technical development, clinical applications, and translational research. It covers MRI across all body systems and disease categories, with particular strength in musculoskeletal, neuroimaging, abdominal, and cardiac MRI.

## Scope Keywords
magnetic resonance imaging, MRI, MR technique, diffusion-weighted imaging, perfusion imaging, MR spectroscopy, contrast agents, gadolinium, liver MRI, cardiac MRI, musculoskeletal MRI, neuroimaging, quantitative MRI, radiomics, deep learning MRI

## Article Types Accepted
- Original Research
- Technical Note
- Review Article
- Case Report (as Brief Report)
- Letter to the Editor
- Pictorial Essay

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Radiology / MRI

## Special Notes
JMRI is the official journal of ISMRM and is the premier MRI-focused journal. It strongly favors studies with MRI-specific technical innovation or clinical validation. AI studies focused on MRI data (segmentation, detection, quantification) are welcomed. The journal values reproducibility and encourages sharing of code and data.

# Journal of Medical Case Reports

## Identity
- **Abbreviation:** J Med Case Rep
- **Publisher:** BMC (Springer Nature)
- **ISSN:** 1752-1947 (electronic)
- **Homepage:** https://jmedicalcasereports.biomedcentral.com/
- **Author guidelines:** https://jmedicalcasereports.biomedcentral.com/submission-guidelines

## Scope
The first international, PubMed-indexed journal devoted exclusively to publishing case reports across all medical disciplines. It welcomes single-patient reports and small case series from any specialty, with particular value placed on cases that add to clinical knowledge, illustrate diagnostic or therapeutic lessons, or describe rare presentations and adverse events.

## Scope Keywords
case report, case series, rare disease, diagnostic dilemma, adverse drug reaction, unusual presentation, clinical lesson, multidisciplinary, all specialties, patient-centered

## Article Types Accepted
- Case Report
- Case Series
- Case Report with literature review

## Classification
- **Tier:** Q3 (case-report-dedicated)
- **Open Access:** Full gold OA, CC BY 4.0 (APC applies — verify current amount)
- **Field:** General medicine / case reports (all specialties)

## Special Notes
Mandatory CARE-aligned structure (Background, Case presentation, Discussion/Conclusions) and **written informed consent for publication** (a copy must be available to the Editor-in-Chief). Encourages the patient's perspective where feasible. Ethics approval or a documented waiver basis is expected for the report. A strong default home when a case does not fit a specialty journal.

## Verification
Identity (publisher, ISSN, OA/CC-BY, CARE + consent requirement) verified 2026-06-15 against a current CC-BY article in the journal (Europe PMC) and the public author-guidelines URL. Specific word/figure/reference limits and the current APC were not independently fetched (publisher page auth-gated) — confirm at the guidelines URL before submission.

# Journal of Nuclear Medicine

## Identity
- **Abbreviation:** JNM, J Nucl Med
- **Publisher:** Society of Nuclear Medicine and Molecular Imaging (SNMMI)
- **ISSN:** 0161-5505 / 2159-662X
- **Homepage:** https://jnm.snmjournals.org/
- **Author guidelines:** https://jnm.snmjournals.org/page/author-instructions

## Scope
JNM publishes original research in nuclear medicine, molecular imaging, and theranostics. Coverage includes PET, SPECT, radionuclide therapy, radiopharmaceuticals, and hybrid imaging (PET/CT, PET/MRI). The journal emphasizes clinical and translational studies involving radiotracer development, dosimetry, and molecular-targeted diagnostics and therapies.

## Scope Keywords
nuclear medicine, PET, SPECT, PET/CT, PET/MRI, radionuclide therapy, theranostics, radiopharmaceuticals, FDG, PSMA, molecular imaging, dosimetry, radiotracer, oncology imaging, neuroendocrine tumors

## Article Types Accepted
- Original Research (Clinical and Basic Science)
- Brief Communication
- Review Article
- State of the Art
- Case Report (Interesting Image)
- Letters to the Editor
- Continuing Education

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (author choice)
- **Field:** Nuclear medicine / Molecular imaging

## Special Notes
JNM is the flagship journal of nuclear medicine. It has strong interest in theranostics (PSMA, Lu-177, etc.) and novel radiotracer development. AI applications in nuclear medicine (automated quantification, lesion detection on PET) are increasingly published. The journal has a companion publication, Journal of Nuclear Medicine Technology.

# Journal of Stroke

## Identity
- **Abbreviation:** J Stroke
- **Publisher:** Korean Stroke Society
- **ISSN:** 2287-6391 (print) / 2287-6405 (online)
- **Homepage:** http://j-stroke.org
- **Author guidelines:** https://j-stroke.org/authors/authors.php

## Scope
Journal of Stroke publishes original research, reviews, guidelines, and special reports on cerebrovascular disease, including epidemiology, risk factors, pathophysiology, diagnosis, acute treatment, secondary prevention, neurorehabilitation, and stroke systems of care. The journal prioritizes clinically translatable work and welcomes international submissions, with a strong tradition of regional stroke research from Asia.

## Scope Keywords
ischemic stroke, hemorrhagic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, transient ischemic attack, acute stroke treatment, thrombolysis, mechanical thrombectomy, stroke prevention, cerebrovascular imaging, cerebral small vessel disease, stroke epidemiology, stroke outcome, neurorehabilitation, stroke guideline

## Article Types Accepted
- Special Review
- Review
- Original Article
- Guideline
- Special Report
- Editorial
- Letter to the Editor
- Response to Letter

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (CC BY-NC 4.0, no APC)
- **Field:** Stroke / cerebrovascular disease

## Special Notes
Official journal of the Korean Stroke Society, published three times per year. Full open access with no article processing charge — a rare combination for a Q1 stroke journal. Editorial Office is hosted at Asan Medical Center, Ulsan University College of Medicine. Structured abstract of 250 words required for Original Articles; references follow Vancouver numbered style. Choose Journal of Stroke over Stroke (AHA) when the target audience is regional (Asia-Pacific) or when no-APC OA is a priority. AI policy: not specified in the author guidelines (last revised 2024-01-31); default to ICMJE — disclose any AI-assisted writing in Methods or Acknowledgments.

# Journal of Vascular and Interventional Radiology

## Identity
- **Abbreviation:** J Vasc Interv Radiol
- **Publisher:** Elsevier (SIR — Society of Interventional Radiology)
- **ISSN:** 1051-0443 / 1535-7732
- **Homepage:** https://www.jvir.org/
- **Author guidelines:** https://www.jvir.org/content/authorinfo

## Scope
JVIR publishes original research, reviews, meta-analyses, and technical reports on vascular and interventional radiology. Coverage spans all IR procedures including embolization, ablation, vascular access, drainage, thrombolysis, and emerging minimally invasive techniques. The journal also covers quality improvement, practice standards, and clinical outcomes research in IR.

## Scope Keywords
interventional radiology, vascular interventions, embolization, tumor ablation, percutaneous biopsy, drainage, thrombolysis, IVC filter, venous access, TIPS, TACE, Y-90 radioembolization, IR outcomes, complication classification, quality improvement, standards of practice, image-guided therapy

## Article Types Accepted
- Clinical Investigation
- Clinical Practice
- Technical Report
- Case Report
- Review Article
- Systematic Review / Meta-Analysis
- Letter to the Editor

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Elsevier OA option)
- **Field:** Radiology / Interventional radiology

## Special Notes
JVIR is the official journal of the Society of Interventional Radiology (SIR). SIR complication classification is mandatory for procedure studies. The journal publishes SIR standards of practice documents and quality improvement studies. JVIR has a North American and international readership. For European-focused IR studies or CBCT-guided intervention meta-analyses, consider CVIR as an alternative or companion target.

# Kidney International

## Identity
- **Abbreviation:** Kidney Int
- **Publisher:** Elsevier (ISN)
- **ISSN:** 0085-2538 / 1523-1755
- **Homepage:** https://www.kidney-international.org
- **Author guidelines:** https://www.kidney-international.org/content/authorinfo

## Scope
Kidney International is a top-tier journal publishing pioneer basic, translational, and clinical studies in nephrology. It covers renal anatomy, physiology, immunology, pathology, and clinical management of acute and chronic kidney disease, dialysis, and transplantation.

## Scope Keywords
renal physiology, renal pathology, glomerulonephritis, polycystic kidney disease, acute kidney injury, chronic kidney disease, diabetic nephropathy, hemodialysis, peritoneal dialysis, kidney transplantation, renal fibrosis, molecular nephrology, mineral bone disorder, hypertension, podocytes, tubulointerstitial nephritis

## Article Types Accepted
- Original Article
- Brief Communication
- In-Depth Review
- Correspondence
- Editorial

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Nephrology (general, flagship)

## Special Notes
Kidney International (IF ~14.8) is highly selective. It enforces a strict limit of 6 combined figures/tables for Original Articles. Case reports are not accepted. AI policy: language editing only, disclose using Elsevier's declaration format before references, AI images banned.

## Verification
- **Source:** Kidney International Guide for Authors, read during maintainer review of PR #330 — verification record: https://github.com/Aperivue/medsci-skills/pull/330#issuecomment-4968075916
- **Date:** 2026-07-14
- **Note:** the 4,000-word body and the ≤300-word structured abstract were confirmed against the journal's own guide. As above, no direct URL was captured and the publisher blocks automated retrieval, so none is asserted here.

# Korean Journal of Radiology

## Identity
- **Abbreviation:** Korean J Radiol
- **Publisher:** Korean Society of Radiology
- **ISSN:** 1229-6929 (Print) / 2005-8330 (Electronic)
- **Homepage:** https://www.kjronline.org/
- **Author guidelines:** https://www.kjronline.org/index.php?body=Instruction

## Scope
KJR publishes original research, reviews, and special articles across all subspecialties of diagnostic and interventional radiology. The journal explicitly excludes radiation oncology, dentistry, dental radiology, dental surgery, and translational/basic nuclear medicine studies. It has particular strength in AI/radiomics, Korean and East Asian population studies, and diseases prevalent in East Asia such as hepatocellular carcinoma, gastric cancer, and thyroid cancer.

## Scope Keywords
diagnostic radiology, AI in radiology, radiomics, deep learning, Korean radiology, hepatocellular carcinoma, thyroid imaging, gastric cancer imaging, CT, MRI, ultrasound, interventional radiology, liver imaging, breast imaging, chest imaging, structured reporting, FDA/medical-device evaluation

## Article Types Accepted
- Original Article
- Brief Research Report
- Review
- Pictorial Essay
- Focus
- Recommendation and Guideline
- Editorial
- Uncover This Tech Term
- Emerging Rad Dx
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (CC BY-NC 4.0, DOAJ indexed)
- **Field:** Radiology (general)

## Special Notes
KJR is the leading English-language radiology journal in Asia, fully open access (USD 100 APC for accepted manuscripts; invited articles, Uncover This Tech Term, Emerging Rad Dx, and Letters are exempt). Indexed in PubMed/MEDLINE, SCIE, and Scopus. Particularly receptive to AI/radiomics studies and Korean population data. Faster turnaround than Western journals (Minor Revision within 30 days; Major Revision within 60 days). A pre-review "technical check" can *unsubmit* a manuscript for deterministic desk items — ascending float citation order (Tables / Supplementary Tables / Figures), demographics in Materials and Methods, one-decimal percentages, double spacing, Acknowledgments on the Title Page only, reporting checklist cited as "Supplementary Material 1", IRB number in Methods even when blinded, and ICMJE forms only after acceptance (see the write-paper profile's Technical-Check Conventions). References: Vancouver style with first six authors listed, then "et al." (≥7 authors). AI policy follows the journal's "Ethical and Responsible Use of Generative AI" statement (KJR 2026; https://doi.org/10.3348/kjr.2026.0166): AI cannot be author or primary scholarly source; AI use beyond routine language assistance must be disclosed in the relevant section or Acknowledgments; AI as study subject must be described in Materials and Methods; reviewers/editors must preserve confidentiality and disclose AI use beyond routine language assistance.

## Acceptance Signals
- **Selectivity band:** selective
- **Desk-reject triggers:** out-of-scope topics (radiation oncology, dentistry/dental radiology, basic nuclear medicine); pre-review "technical check" can *unsubmit* for deterministic format items (ascending float citation order, demographics in Materials and Methods, one-decimal percentages, double spacing, Acknowledgments on Title Page only, reporting checklist as "Supplementary Material 1", IRB number in Methods even when blinded)
- **Design expectations:** solid original studies; particularly receptive to AI/radiomics and Korean / East Asian population data
- **Study-type tolerance:** broad (Original Article, Brief Research Report, plus short formats such as Uncover This Tech Term and Emerging Rad Dx)
- **Review process:** pre-review technical-check desk gate; fast turnaround (Minor ≤30 d, Major ≤60 d); ICMJE forms only after acceptance
- **Cascade / transfer:** full-OA society journal; peer Asian / society radiology journals as tier-equivalents

## Verification
- **Source:** KJR-Instructions-202603.pdf (March 2026 official author instructions)
- **Date:** 2026-05-21

# Korean Circulation Journal (KCJ)

## Identity
- **Abbreviation:** Korean Circ J
- **Publisher:** The Korean Society of Cardiology / The Korean Cardiac Research Foundation
- **ISSN:** 1738-5520 (print) / 1738-5555 (online)
- **Homepage:** https://e-kcj.org/
- **Author guidelines:** https://e-kcj.org/index.php?body=instructions

## Scope
KCJ is the official journal of the Korean Society of Cardiology, covering all aspects of cardiovascular medicine including original research of preclinical and clinical findings, state-of-the-art reviews, perspectives for outbreaking issues, editorials, images in cardiovascular medicine, and letters to the editor.

## Scope Keywords
cardiology, cardiovascular disease, Korean cohort, clinical cardiology, coronary artery disease, atherosclerosis, heart failure, arrhythmia, hypertension, preventive cardiology, cardiac imaging, Asian cardiology, KSC official journal

## Article Types Accepted
- Original Research
- State of the Art Review
- Perspective
- Image in Cardiovascular Medicine
- Letter to the Editor
- Research Letter

## Classification
- **Tier:** Q3 (Korean society flagship)
- **Open Access:** Open Access, peer-reviewed, monthly
- **Field:** Cardiology — Korean Society of Cardiology flagship

## Special Notes
Editor-in-Chief In-Ho Chae, MD, PhD. Original Research capped at **5,000 words**, 8 figures/tables, with a **250-word structured abstract using Background and Objectives / Methods / Results / Conclusions**. State of the Art Reviews ≤10,000 words. Perspectives ≤2,000 words, 4 figures/tables; Research Letter ≤800 words, 1 figure/table; Letter to the Editor ≤500 words. References use **Vancouver style with numbered references in citation order**; "List all authors if 6 or fewer; otherwise, list the first 3 and add et al." Submission portal: https://kcj.edmgr.com. **AI policy is not displayed on the Instructions for Authors page** as of the audit date — refer directly to KCJ's editorial office for AI disclosure expectations. APC not specified on the guidelines page; verify at the journal's open-access policy page if Gold OA is needed. Natural home for Korean cardiovascular cohort papers that need a guaranteed publication path and KSC community visibility — best used as a safety-net target in a cascade strategy or as primary when Korean clinical-practice relevance is the dominant framing.


---

## Verification
- **Source:** https://e-kcj.org/index.php?body=instructions
- **Date (harvested from a local profile library):** 2026-05
- **Date (promoted to public):** 2026-05-21

# Korean Journal of Internal Medicine

## Identity
- **Abbreviation:** KJIM
- **Publisher:** Korean Association of Internal Medicine
- **ISSN:** 1226-3303 / 2005-6648
- **Homepage:** https://www.kjim.org/
- **Author guidelines:** https://www.kjim.org/authors/authors.php

## Scope
KJIM publishes original research, reviews, and clinical case reports across all subspecialties of internal medicine — endocrinology, gastroenterology, hematology-oncology, infectious diseases, nephrology, pulmonology, rheumatology, cardiology, geriatrics — with emphasis on Korean and East Asian clinical research.

## Scope Keywords
internal medicine, Korean cohort, East Asian medicine, endocrinology, gastroenterology, hematology, oncology, infectious disease, nephrology, pulmonology, rheumatology, cardiology, geriatrics, health screening, NHIS, clinical research, observational cohort

## Article Types Accepted
- Original Article
- Review
- Editorial
- Images of Interest
- Correspondence

## Classification
- **Tier:** Q2 (general internal medicine; verify current JCR rank)
- **Open Access:** Full OA (CC BY-NC); APC $1,000 for Original Articles (2024-10-01)
- **Field:** Internal medicine (general)

## Special Notes
Korean Association of Internal Medicine flagship; bimonthly publication; PubMed/PMC indexed; structured abstract requires Background/Aims, Methods, Results, Conclusions; KJIM-specific "Key Message" section is mandatory in Original Articles. Initial decision typically within 4 weeks. AI policy: mandatory AI disclosure in Acknowledgments with model name + version + source + application method; AI cannot be listed as author.


---

## Verification
- **Source:** https://www.kjim.org/authors/authors.php
- **Date:** 2026-05-21

# Lancet Diabetes & Endocrinology

## Identity
- **Abbreviation:** Lancet Diabetes Endocrinol
- **Publisher:** Elsevier (The Lancet Group)
- **ISSN:** 2213-8587 / 2213-8595
- **Homepage:** https://www.thelancet.com/journals/landia/home
- **Author guidelines:** https://www.thelancet.com/landia/information-for-authors

## Scope
Lancet Diabetes & Endocrinology publishes original research, reviews, and clinical studies in diabetes, endocrinology, and metabolism. Coverage includes type 1 and type 2 diabetes, obesity, thyroid disorders, adrenal disorders, pituitary disease, bone and mineral metabolism, reproductive endocrinology, and metabolic syndrome. The journal prioritizes large clinical trials, epidemiological studies, and translational research with global health implications.

## Scope Keywords
diabetes mellitus, type 2 diabetes, type 1 diabetes, obesity, thyroid disease, endocrinology, metabolic syndrome, insulin resistance, GLP-1 receptor agonist, HbA1c, diabetic complications, adrenal insufficiency, Cushing syndrome, osteoporosis, pituitary adenoma, PCOS, gestational diabetes

## Article Types Accepted
- Original Research (Articles)
- Review
- Series
- Seminar
- Comment
- Correspondence
- Clinical Picture
- Viewpoint

## Classification
- **Tier:** Q1
- **Impact Factor:** ~42
- **Open Access:** Hybrid
- **Field:** Endocrinology / Diabetes

## Special Notes
Lancet Diabetes & Endocrinology is the premier endocrinology/diabetes specialty journal within the Lancet family. Extremely competitive (acceptance rate <10%). Publishes landmark diabetes trials (e.g., SGLT2 inhibitor, GLP-1 RA outcomes). Imaging studies accepted only when part of major clinical trials (e.g., body composition imaging, pancreatic imaging in diabetes). Follows Lancet Group editorial standards: strict adherence to ICMJE, EQUATOR checklists mandatory, and preference for large multicenter international RCTs or prospective cohorts.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Restrictive — Lancet Group policy permits AI for language editing only; AI cannot contribute to scientific content generation; AI cannot be listed as author
- **Disclosure location:** Acknowledgments section
- **AI-generated images:** Not permitted for scientific content
- **Policy URL:** https://www.thelancet.com/landia/information-for-authors

# Lancet Gastroenterology & Hepatology

## Identity
- **Abbreviation:** Lancet Gastroenterol Hepatol
- **Publisher:** Elsevier (The Lancet Group)
- **ISSN:** 2468-1253
- **Homepage:** https://www.thelancet.com/journals/langas/home
- **Author guidelines:** https://www.thelancet.com/langas/information-for-authors

## Scope
The Lancet Gastroenterology & Hepatology publishes original research, reviews, comments, and clinical studies across the full spectrum of gastroenterology and hepatology. The journal favors large clinical trials, multicentre or population-scale epidemiology, evidence-synthesis (Cochrane-style and individual-patient-data meta-analyses), and translational studies with global health implications. Within hepatology it has been a primary venue for MASLD/NAFLD natural-history evidence (e.g., Hagström 2024 systematic review of natural-history rates), nomenclature debate following the 2023 multisociety Delphi statement, hepatitis B/C elimination programmes, and cirrhosis/portal-hypertension management trials.

## Scope Keywords
gastroenterology, hepatology, MASLD, NAFLD, MASH, MetALD, ALD, alcohol-associated liver disease, viral hepatitis, hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, portal hypertension, IBD, Crohn's disease, ulcerative colitis, irritable bowel syndrome, gastrointestinal cancer, liver transplantation, FIB-4, natural history, comparator-refinement methodology, large-cohort epidemiology, Cochrane meta-analysis

## Article Types Accepted
- Articles (Original Research; large RCTs, observational cohort, IPD meta-analysis)
- Review
- Series (commissioned thematic series)
- Seminar
- Comment (invited editorial)
- Correspondence
- Clinical Picture
- Viewpoint
- Personal View

## Classification
- **Tier:** Q1 gastroenterology and hepatology (top-tier specialty journal in Lancet group)
- **Open Access:** Hybrid (OA optional; APC ~US$5,500 for Gold OA)
- **Field:** gastroenterology and hepatology — clinical, epidemiological, translational

## Special Notes
**Submission guidelines are a near-verbatim shared template across the Lancet Group specialty journals (Lancet Diabetes & Endocrinology, Lancet GH, Lancet Respiratory Medicine, etc.) — same article structure, abstract, statement-of-novelty wording, AI policy, and supplementary requirements.** Beyond what the guidelines disclose, the practically relevant non-guideline factors for this venue are documented below.

### Editorial culture (non-guideline)
- **Pre-submission inquiry strongly advised.** ~60–70 % desk-reject rate for original research; pre-submission inquiry (1-page abstract + cover letter to editor@lancet.com) is the standard route to test scope fit before full submission. Decisions on inquiries typically arrive within 5–10 working days.
- **Strong preference for "what changes practice or guideline" framing** in cover letter and Discussion. Methodology-only papers (e.g., comparator refinement as method) need an explicit "how this will change MASLD natural-history evidence appraisal worldwide" paragraph.
- **Research in Context box mandatory at acceptance** (separate from abstract): three sub-headings (Evidence before this study / Added value of this study / Implications of all the available evidence). Drafting it pre-submission helps internal triage even though it is not officially required at initial submission.
- **Statement of novelty / data-sharing statement mandatory** in cover letter (not in main paper). Lancet Group requires deposition pathway specified at submission, not at revision.

### MASLD-natural-history precedent
- The journal has been the de-facto reference venue for MASLD natural-history evidence since 2024 (Hagström L, et al. Clinical and prognostic outcomes after hepatocellular cancer screening, Lancet Gastroenterol Hepatol; and the post-2023 Delphi nomenclature commentaries). A Korean health-screening cohort applying the 2023 nomenclature with comparator-refinement methodology is a direct continuation of that line of evidence.
- Reviewer pool overlaps substantially with Hepatology (AASLD), Journal of Hepatology (EASL), and Hepatology International (APASL). Suggested reviewers from these venues are typical.

### Korean cohort context
- East-Asian cohort epidemiology is regularly published, but the journal has a documented preference for *international or multi-cohort* validation (e.g., paired Korean + UK Biobank + NHANES analyses). Single-centre Korean cohorts are accepted when the methodological contribution (e.g., comparator refinement as a generalizable method) is strong enough to justify international relevance — the cover letter should pre-empt the "single-centre / Asian-only" reviewer concern.

## Acceptance Rate (estimated)
~5–8 % overall (Lancet specialty journals' published acceptance bands; ~60–70 % desk-rejected before peer review, of the remainder ~25–35 % accepted).

# The Lancet Infectious Diseases

## Identity
- **Abbreviation:** Lancet Infect Dis
- **Publisher:** Elsevier (Lancet Group)
- **ISSN:** 1473-3099 / 1474-4457
- **Homepage:** https://www.thelancet.com/journals/laninf
- **Author guidelines:** https://www.thelancet.com/laninf/information-for-authors

## Scope
The Lancet Infectious Diseases publishes high-impact original research, reviews, and commentary on all aspects of infectious diseases, including clinical, public health, and microbiological perspectives. It prioritizes studies with global health significance, large-scale trials, and translational findings relevant to infection prevention, diagnosis, and treatment.

## Scope Keywords
infectious diseases, global health, antimicrobial resistance, vaccines, HIV/AIDS, tuberculosis, malaria, emerging infections, pandemic preparedness, clinical trials, epidemiology, infection control, antimicrobial stewardship, neglected tropical diseases, outbreak response, diagnostics, public health interventions

## Article Types Accepted
- Original Research (Articles)
- Review
- Personal View
- Comment
- Correspondence
- Series
- Health Policy

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (optional OA)
- **Field:** Infectious diseases

## Special Notes
The Lancet Infectious Diseases is the leading specialty journal in ID with IF ~31. It shares the Lancet Group submission system and editorial standards; manuscripts rejected from The Lancet may be transferred. The journal strongly favors large multicenter trials, systematic reviews with global scope, and policy-relevant epidemiological studies.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Language editing only (not intellectual contribution)
- **Disclosure location:** Acknowledgments
- **AI-generated images:** Not permitted without disclosure
- **Policy URL:** https://www.thelancet.com/laninf/information-for-authors

# Lancet Neurology

## Identity
- **Abbreviation:** Lancet Neurol
- **Publisher:** Lancet / Elsevier
- **ISSN:** 1474-4422 / 1474-4465
- **Homepage:** https://www.thelancet.com/journals/laneur/home
- **Author guidelines:** https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(00)X0015-0/fulltext

## Scope
The Lancet Neurology publishes original research, reviews, and personal views across all areas of clinical neurology and neuroscience with clinical relevance. Coverage includes stroke, dementia, epilepsy, movement disorders, multiple sclerosis, neuro-oncology, neuromuscular disease, neuroinfection, and headache. The journal prioritizes large-scale clinical trials, major epidemiological studies, and translational research that advances patient care in neurological disease.

## Scope Keywords
neurology, stroke, dementia, Alzheimer disease, epilepsy, Parkinson disease, multiple sclerosis, movement disorders, neuro-oncology, neuromuscular disease, headache, traumatic brain injury, neuroimmunology, clinical neuroscience, neurodegeneration

## Article Types Accepted
- Original Research (Articles)
- Review
- Series
- Seminar
- Personal View
- Comment
- Correspondence

## Classification
- **Tier:** Q1
- **Impact Factor:** ~45
- **Open Access:** Hybrid
- **Field:** Neurology

## Special Notes
The Lancet Neurology is the highest-impact specialty neurology journal. It shares the Lancet Group editorial policies, formatting requirements, and submission platform. Manuscripts must have a structured Summary (Background, Methods, Findings, Interpretation, Funding). The journal is highly selective (~5% acceptance) and favors multicenter RCTs, landmark cohort studies, and comprehensive systematic reviews that shape clinical practice or guidelines.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** AI tools may assist with writing but cannot be authors; authors retain full responsibility
- **Disclosure location:** Acknowledgments or Methods section
- **AI-generated images:** Must be disclosed
- **Policy URL:** https://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-for-authors.pdf

# Lancet Oncology

## Identity
- **Abbreviation:** Lancet Oncol
- **Publisher:** Lancet / Elsevier
- **ISSN:** 1470-2045 / 1474-5488
- **Homepage:** https://www.thelancet.com/journals/lanonc
- **Author guidelines:** https://www.thelancet.com/lanonc/information-for-authors

## Scope
Lancet Oncology publishes original research, reviews, and policy-focused content in clinical and translational oncology. It prioritizes large-scale international clinical trials, practice-changing therapeutic advances, cancer prevention and screening, and global oncology health policy. As part of the Lancet family, it values broad clinical impact, global health perspectives, and evidence that shapes cancer care delivery worldwide.

## Scope Keywords
clinical oncology, cancer, clinical trial, immunotherapy, targeted therapy, radiation oncology, surgical oncology, cancer prevention, screening, global oncology, health policy, precision medicine, cancer genomics, biomarkers, cancer epidemiology, survivorship, international multicenter, translational oncology

## Article Types Accepted
- Article (Original Research)
- Review
- Series
- Viewpoint
- Comment
- Correspondence
- Personal View
- Commission

## Classification
- **Tier:** Q1
- **Impact Factor:** ~36
- **Open Access:** Hybrid (optional OA)
- **Field:** Oncology

## Special Notes
Lancet Oncology is part of the Lancet Group and shares its editorial philosophy of broad clinical and policy impact. Transfer system within Lancet family (The Lancet, Lancet Digital Health, eClinicalMedicine). Lancet-style unstructured summary followed by structured research-in-context panel. The journal values international multicenter studies and global oncology perspectives. AI studies may be redirected to Lancet Digital Health unless demonstrating direct oncology clinical impact.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Language editing only — Acknowledgments disclosure required (Lancet Group policy)
- **Disclosure location:** Acknowledgments section
- **AI-generated images:** Must be disclosed; fabrication/falsification policies apply
- **Policy URL:** https://www.thelancet.com/lanonc/information-for-authors

# The Lancet Psychiatry

## Identity
- **Abbreviation:** Lancet Psychiatry
- **Publisher:** Lancet Group / Elsevier
- **ISSN:** 2215-0366 / 2215-0374
- **Homepage:** https://www.thelancet.com/journals/lanpsy
- **Author guidelines:** https://www.thelancet.com/lanpsy/information-for-authors

## Scope
The Lancet Psychiatry publishes high-quality original research, reviews, and commentary in psychiatry and mental health. The journal emphasizes clinical research with global relevance, including large-scale clinical trials, epidemiologic studies, health services research, and policy-relevant investigations. It covers the full range of psychiatric conditions and prioritizes work that advances understanding, prevention, and treatment of mental illness worldwide.

## Scope Keywords
psychiatry, mental health, depression, psychosis, schizophrenia, bipolar disorder, anxiety, suicide prevention, substance use, global mental health, psychopharmacology, psychotherapy, clinical trial, epidemiology, health policy, child and adolescent psychiatry, forensic psychiatry, neuropsychiatry, digital psychiatry

## Article Types Accepted
- Article (Original Research)
- Review
- Series
- Comment
- Correspondence
- Personal View
- Health Policy

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (optional OA)
- **Field:** Psychiatry

## Special Notes
The Lancet Psychiatry is part of the Lancet family of journals. It has a strong global health and health policy orientation, emphasizing studies from low- and middle-income countries alongside high-income settings. The journal favors large RCTs, individual participant data meta-analyses, and studies with direct policy implications. Submissions follow Lancet Group conventions (structured Summary, no structured Introduction/Discussion).

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Language editing only
- **Disclosure location:** Acknowledgments
- **AI-generated images:** Disclosure required if used
- **Policy URL:** https://www.thelancet.com/lanpsy/information-for-authors

# The Lancet Public Health

## Identity
- **Abbreviation:** Lancet Public Health
- **Publisher:** Elsevier (The Lancet Group)
- **ISSN:** 2468-2667
- **Homepage:** https://www.thelancet.com/journals/lanpub/home
- **Author guidelines:** https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00248-3/fulltext

## Scope
The Lancet Public Health publishes original research, reviews, and commentary addressing population health, health equity, and public health policy worldwide. It prioritizes studies with implications for health systems, disease prevention, social determinants of health, and population-level interventions, with particular emphasis on global and underserved populations.

## Scope Keywords
public health, population health, health equity, epidemiology, health policy, social determinants, prevention, disease burden, global health, health systems, screening, vaccination, environmental health, non-communicable disease, health disparities

## Article Types Accepted
- Article (original research)
- Review
- Series
- Comment
- Correspondence
- Viewpoint

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (no APC — Lancet Group covers costs)
- **Field:** Public health / General medicine

## Special Notes
The Lancet Public Health is fully open access with no author charges, making it unique among high-impact public health journals. It follows Lancet Group formatting (unstructured summary, ~150 words; panels for key messages). Highly selective (~8% acceptance). Strong emphasis on health equity and LMIC research. Requires data sharing statement and EQUATOR checklist. AI policy: language editing only, Acknowledgments disclosure required, AI images banned (Lancet Group policy).

# Lancet Respiratory Medicine

## Identity
- **Abbreviation:** Lancet Respir Med
- **Publisher:** Lancet / Elsevier
- **ISSN:** 2213-2600 / 2213-2619
- **Homepage:** https://www.thelancet.com/journals/lanres/home
- **Author guidelines:** https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(13)X0014-4/fulltext

## Scope
The Lancet Respiratory Medicine publishes original research, reviews, and commentary on all aspects of respiratory medicine including asthma, COPD, interstitial lung disease, pulmonary infections (including COVID-19 and tuberculosis), lung cancer, pulmonary vascular disease, cystic fibrosis, sleep-disordered breathing, and critical care. The journal prioritizes large-scale clinical trials, epidemiological studies, and translational research with direct implications for patient care and public health.

## Scope Keywords
respiratory medicine, COPD, asthma, lung cancer, interstitial lung disease, pulmonary fibrosis, pneumonia, tuberculosis, COVID-19, pulmonary hypertension, critical care, mechanical ventilation, sleep medicine, cystic fibrosis, pulmonology

## Article Types Accepted
- Original Research (Articles)
- Review
- Series
- Seminar
- Personal View
- Comment
- Correspondence

## Classification
- **Tier:** Q1
- **Impact Factor:** ~33
- **Open Access:** Hybrid
- **Field:** Pulmonology

## Special Notes
The Lancet Respiratory Medicine is the highest-impact specialty respiratory journal. It shares the Lancet Group editorial policies and submission platform. Manuscripts require a structured Summary (Background, Methods, Findings, Interpretation, Funding). The journal is highly selective and favors practice-changing RCTs, landmark observational studies, and high-quality meta-analyses. Lung imaging AI and CT screening studies are relevant if they demonstrate clinical outcome benefit.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** AI tools may assist with writing but cannot be authors; authors retain full responsibility
- **Disclosure location:** Acknowledgments or Methods section
- **AI-generated images:** Must be disclosed
- **Policy URL:** https://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-for-authors.pdf

# Liver International

## Identity
- **Abbreviation:** Liver Int
- **Publisher:** John Wiley & Sons
- **ISSN:** 1478-3223 / 1478-3231
- **Homepage:** https://onlinelibrary.wiley.com/journal/14783231
- **Author guidelines:** https://onlinelibrary.wiley.com/page/journal/14783231/homepage/forauthors.html
- **Verification:** 2026-05-21 (against Wiley AGL PDF)

## Scope
Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies, publishing high-quality original research with clear clinical or translational significance. International multi-disciplinary forum for clinicians and basic scientists working on normal and abnormal structure and function of the liver.

## Scope Keywords
hepatology, liver disease, MASLD, NAFLD, MetALD, ALD, chronic hepatitis B, chronic hepatitis C, HCC, cirrhosis, liver fibrosis, FIB-4, liver transplantation, translational hepatology, liver biomarkers, cholangiopathy, acute liver failure, portal hypertension, clinical hepatology, basic hepatology

## Article Types Accepted
- Original Article
- Systematic Review / Meta-Analysis
- Brief Definitive Report
- Review Article (invited; unsolicited considered)
- Research Letter (within 6 months of cited paper; 1 per issue)
- Editorial (invited)
- Letter to the Editor (no case reports accepted)
- Liver International Images

## Classification
- **Tier:** Q1 hepatology
- **Open Access:** Hybrid (standard copyright OR CC license with APC)
- **Field:** hepatology, clinical and translational liver research

## Special Notes
Explicit policy rejecting purely descriptive research, methodology-only papers, and case reports. Clinical trial registration mandatory (prospective registration; retrospective rejected). PRISMA checklist required for systematic reviews (auto-rejection otherwise). Continuous Publication model — no issue pagination. Lay Summary mandatory on revised Original Articles. AI policy: follows Wiley/ICMJE — disclose AI use in Methods or Acknowledgements; AI cannot be author; AI-generated image policy follows Wiley publisher-wide guidance (verify at journal homepage for any journal-specific amendments).

# Medical Image Analysis

## Identity
- **Abbreviation:** Med Image Anal, MedIA
- **Publisher:** Elsevier
- **ISSN:** 1361-8415 / 1361-8423
- **Homepage:** https://www.sciencedirect.com/journal/medical-image-analysis
- **Author guidelines:** https://www.elsevier.com/journals/medical-image-analysis/1361-8415/guide-for-authors

## Scope
Medical Image Analysis publishes original research on computational methods for medical image analysis, including segmentation, registration, detection, classification, and reconstruction. The journal bridges computer science and medical imaging, emphasizing novel algorithms validated on medical image data across all modalities (CT, MRI, X-ray, pathology, microscopy, ultrasound).

## Scope Keywords
medical image analysis, image segmentation, image registration, object detection, deep learning, convolutional neural networks, medical image classification, computer-aided diagnosis, pathology image analysis, 3D reconstruction, image-guided intervention, multi-modal fusion, semi-supervised learning, data augmentation, benchmark datasets

## Article Types Accepted
- Original Article
- Short Communication
- Review Article
- Position Paper

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Medical AI / Medical image computing

## Special Notes
Medical Image Analysis is the premier journal for computational medical image analysis research. It expects rigorous technical methodology with quantitative evaluation on medical datasets. Papers typically require comparison against state-of-the-art methods, ablation studies, and evaluation on multiple datasets. Clinical validation is valued but not required if the technical contribution is substantial. The journal has high standards for reproducibility.

# Nature Machine Intelligence

## Identity
- **Abbreviation:** Nat Mach Intell
- **Publisher:** Springer Nature
- **ISSN:** 2522-5839
- **Homepage:** https://www.nature.com/natmachintell/
- **Author guidelines:** https://www.nature.com/natmachintell/submission-guidelines

## Scope
Nature Machine Intelligence publishes research on machine learning, artificial intelligence, and robotics, with emphasis on studies that demonstrate significant methodological advances or impactful applications. Medical AI papers are published when they introduce novel algorithms, architectures, or learning paradigms with broad applicability beyond a single clinical domain.

## Scope Keywords
machine learning, deep learning, artificial intelligence, neural networks, computer vision, natural language processing, reinforcement learning, generative models, foundation models, AI methodology, medical AI, self-supervised learning, transfer learning, explainable AI, robotics

## Article Types Accepted
- Article (original research)
- Brief Communication
- Review
- Perspective
- Comment
- Correspondence
- Analysis

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (Springer Nature transformative agreements)
- **Field:** Computer science / Artificial intelligence

## Special Notes
Nature Machine Intelligence is a top-tier venue for AI methodology. Medical AI papers published here typically introduce novel architectures or training paradigms that are evaluated on medical data but have broader AI significance. Pure clinical validation studies without methodological novelty are better suited to clinical or radiology journals. The journal has strong interest in foundation models, multimodal learning, and AI safety/ethics.

# Nature Medicine

## Identity
- **Abbreviation:** Nat Med
- **Publisher:** Springer Nature
- **ISSN:** 1078-8956 / 1546-170X
- **Homepage:** https://www.nature.com/nm/
- **Author guidelines:** https://www.nature.com/nm/submission-guidelines

## Scope
Nature Medicine publishes research that bridges basic and clinical science, with emphasis on translational studies that advance understanding of disease mechanisms, improve diagnostics, or develop novel therapies. The journal favors studies with clear translational impact, including clinical trials, biomarker discovery, and technology-driven advances in medicine.

## Scope Keywords
translational medicine, clinical trials, biomarkers, precision medicine, oncology, immunology, genomics, drug development, disease mechanisms, therapeutic targets, diagnostics, medical AI, digital health, gene therapy, cell therapy

## Article Types Accepted
- Article (original research)
- Brief Communication
- Review
- Perspective
- Correspondence
- Analysis
- Resource
- Technical Report

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (Springer Nature transformative agreements may cover OA)
- **Field:** General medicine / Translational science

## Special Notes
Nature Medicine is highly receptive to medical AI studies that demonstrate clinical validation at scale. It values multi-center studies, external validation, and studies that combine novel methodology with clinical endpoints. Acceptance requires work at the intersection of innovation and clinical relevance. Preprints are allowed and even encouraged.

## AI Writing Disclosure Policy
- **Requirement level:** Required
- **Permitted scope:** Language editing only
- **Disclosure location:** Methods
- **AI-generated images:** Banned
- **Policy URL:** https://www.nature.com/nature-portfolio/editorial-policies/ai

# The New England Journal of Medicine

## Identity
- **Abbreviation:** NEJM, N Engl J Med
- **Publisher:** Massachusetts Medical Society
- **ISSN:** 0028-4793 / 1533-4406
- **Homepage:** https://www.nejm.org/
- **Author guidelines:** https://www.nejm.org/author-center/new-manuscripts

## Scope
The New England Journal of Medicine publishes original research, reviews, and editorial opinion on all aspects of medicine, with emphasis on studies that have immediate relevance to clinical practice. It prioritizes large randomized controlled trials, landmark observational studies, and practice-changing discoveries across all medical specialties.

## Scope Keywords
clinical trials, randomized controlled trial, evidence-based medicine, internal medicine, surgery, oncology, cardiology, infectious disease, public health, therapeutics, drug efficacy, clinical outcomes, mortality, morbidity, practice-changing

## Article Types Accepted
- Original Article
- Special Article
- Review Article
- Clinical Practice
- Case Records of the Massachusetts General Hospital
- Clinical Problem-Solving
- Images in Clinical Medicine
- Correspondence
- Editorials

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (selected articles OA; most subscription)
- **Field:** General medicine

## Special Notes
NEJM is the highest-impact general medical journal. Manuscripts must demonstrate clear clinical significance with large sample sizes and robust methodology. AI/radiology papers are occasionally published if they demonstrate practice-changing clinical impact validated in large trials. Extremely competitive with single-digit acceptance rate.

# NEJM AI

## Identity
- **Abbreviation:** NEJM AI
- **Publisher:** NEJM Group (Massachusetts Medical Society)
- **ISSN:** 2836-9386 (digital-only)
- **Homepage:** https://ai.nejm.org/
- **Author guidelines:** https://ai.nejm.org/author-center

## Scope
Interdisciplinary NEJM Group journal on AI/ML in clinical medicine, intentionally pairing "pre-clinical" and clinical articles. Covers AI methodologies and data science applied to biomedical informatics, connected health, telemedicine, **medical images and imaging**, personalized medicine, policy/regulation, and the ethical and medicolegal implications of AI. Holds AI to the same clinical-evidence bar as other interventions; rigorous statistical and methodological review.

## Scope Keywords
medical AI, machine learning, clinical evaluation of AI, AI safety, medical imaging AI, foundation models in medicine, large language models, clinical decision support, biomedical informatics, benchmarks, datasets, reproducible protocols, algorithmic bias and fairness, AI regulation and policy, prospective validation, reader study, multi-reader multi-case, diagnostic AI

## Article Types Accepted
- Original Article (≤3,000 words; 300-word structured abstract; ≤5 tables/figures)
- Datasets, Benchmarks, and Protocols (≤3,000 words; immediately full OA)
- Case Study (≤2,000 words)
- Review (≤3,000 words)
- Perspective (≤1,200 words)
- Policy Corner (≤2,000 words)
- Editorial (≤1,000 words)
- Letter (≤400 words)

## Classification
- **Tier:** Top-tier (NEJM Group brand; no JCR Impact Factor yet — launched 2024)
- **Open Access:** No APC / no submission or publication fees; Author Accepted Manuscript deposit (CC BY-NC-ND default; CC BY-ND / CC BY for certain funders). Datasets, Benchmarks, and Protocols are fully OA immediately on publication.
- **Field:** Medical AI / clinical evaluation of AI

## Special Notes
- **Word limit 3,000** for Original Article and Datasets/Benchmarks/Protocols (intro→discussion; excludes abstract/legends/table notes) — very tight.
- **ONE corresponding author only** at submission/revision (co-corresponding allowed only after acceptance; original remains guarantor). Co-first/co-senior allowed with an "equal contribution" note.
- **Structured abstract = Background / Methods / Results / Conclusions** (4-heading) ≤300 words + a 1–2 sentence short description.
- **COI via Convey** (online), not ICMJE PDF forms. AI-use disclosed in **both cover letter and manuscript**; AI cannot be an author.
- **Statistical review** mandatory (team of statistical editors). Observational studies: signed/dated prespecified SAP encouraged; multiplicity control or limit secondary/exploratory to point estimates + 95% CI (no P values); encourage retest in an independent study.
- **Diversity/representativeness supplementary table** required for clinical research studies.
- Single-blind review, ≥2 reviewers + methodological review; reviews requested within ~2 weeks (NEJM-family fast triage). **No presubmission inquiries.** Preprints allowed (e.g., medRxiv); cascades from NEJM allowed. Reporting: recommends **TRIPOD-AI or MI-CLAIM**. Contact: editorial.ai@nejm.org.

# Neuroradiology

## Identity
- **Abbreviation:** Neuroradiology
- **Publisher:** Springer Nature (European Society of Neuroradiology)
- **ISSN:** 0028-3940 / 1432-1920
- **Homepage:** https://www.springer.com/journal/234
- **Author guidelines:** https://www.springer.com/journal/234/submission-guidelines

## Scope
Neuroradiology publishes original research, reviews, and case reports on imaging of the brain, spine, head and neck, and peripheral nervous system. It covers all neuroimaging modalities (CT, MRI, angiography, ultrasound) and spans neuro-oncology, cerebrovascular disease, neurodegeneration, pediatric neuroradiology, and interventional neuroradiology.

## Scope Keywords
neuroradiology, brain imaging, spine imaging, head and neck imaging, neuroimaging, stroke imaging, brain tumor, multiple sclerosis, cerebrovascular, intracranial aneurysm, interventional neuroradiology, perfusion imaging, diffusion tensor imaging, pediatric neuroimaging, MRI brain

## Article Types Accepted
- Original Article
- Review Article
- Diagnostic Neuroradiology (case-based)
- Interventional Neuroradiology
- Technical Note
- Letter to the Editor
- Pictorial Review

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Springer transformative agreements)
- **Field:** Radiology / Neuroradiology

## Special Notes
Neuroradiology is the official journal of the European Society of Neuroradiology (ESNR). It accepts both diagnostic and interventional neuroradiology studies. Case reports are published under the "Diagnostic Neuroradiology" category. AI applications in brain and spine imaging are welcomed. The journal has a relatively fast review process compared to general radiology journals.

# npj Digital Medicine

## Identity
- **Abbreviation:** npj Digit. Med.
- **Publisher:** Nature Portfolio (Springer Nature)
- **ISSN:** 2398-6352 (online only)
- **Homepage:** https://www.nature.com/npjdigitalmed/
- **Author guidelines:** https://www.nature.com/npjdigitalmed/submission-guidelines

## Scope
High-impact Nature-family journal publishing original research on digital technologies transforming healthcare, including AI/ML diagnostics, wearables, mobile health, digital biomarkers, and clinical decision support. Emphasizes translational impact with rigorous validation and reproducibility (code/data availability mandatory).

## Scope Keywords
digital medicine, artificial intelligence, machine learning, wearable sensors, digital biomarkers, mobile health, clinical decision support, remote patient monitoring, deep learning, digital therapeutics, health data science, predictive analytics, electronic health records, federated learning, computer vision in medicine, natural language processing

## Article Types Accepted
- Article
- Review
- Brief Communication
- Perspective
- Comment

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (CC BY 4.0)
- **Field:** Digital health / Medical AI

## Special Notes
Nature Portfolio flagship for digital health; desk reject rate >50%. Methods section placed after Discussion (Nature convention). Data and Code Availability statements mandatory. Preprints encouraged. AI policy: LLMs cannot be authors; document AI tool use in Methods section.

# Nutrition, Metabolism and Cardiovascular Diseases (NMCD)

## Identity
- **Abbreviation:** Nutr Metab Cardiovasc Dis
- **Publisher:** Elsevier
- **ISSN:** 0939-4753 (print) / 1590-3729 (online)
- **Homepage:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases
- **Author guidelines:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases/publish/guide-for-authors

## Scope
NMCD is an international forum focusing on the relationship between nutritional and metabolic alterations and cardiovascular disorders. The journal addresses diabetes, atherosclerosis, hypertension, and other nutrition-related diseases through original clinical and experimental research in preventive medicine and vascular biology.

## Scope Keywords
cardio-metabolic, nutrition, metabolism, diabetes, atherosclerosis, hypertension, dyslipidemia, metabolic syndrome, cardiovascular-kidney-metabolic, CKM staging, obesity, insulin resistance, preventive medicine, vascular biology, lifestyle intervention, observational cohort, Mediterranean diet

## Article Types Accepted
- Original Article
- Systematic Review
- Meta-analysis
- Viewpoint / Short Review
- Institutional Review
- Short Communication
- Letter to the Editor

## Classification
- **Tier:** Q1–Q2 (cardiovascular / nutrition crossover)
- **Open Access:** Hybrid — APC USD 3,560 for gold open access; subscription model available
- **Field:** Cardio-metabolic medicine — nutrition and vascular biology crossover

## Special Notes
Editor-in-Chief Giovanni Targher, MD (Verona, Italy). Original Articles capped at **4,000 words**, 6 figures/tables, 60 references, with a **structured 250-word abstract: Background and Aims / Methods and Results / Conclusion**. Systematic Reviews and Meta-analyses permit 6,000 words, 120 references, 8 figures/tables. References use **numbered format [1], [2] in order of citation; first 6 authors should be listed followed by 'et al.'**. AI policy: declaration required on submission, with a dedicated statement before the references reading "During the preparation of this work the author(s) used [NAME OF TOOL / SERVICE] in order to [REASON]"; AI cannot be listed as author; basic grammar/spell-check tools exempt. Submission portal: https://www.editorialmanager.com/nmcd. Choose NMCD when the manuscript foregrounds the nutrition–metabolism–CVD axis (e.g., Mediterranean diet, metabolic syndrome cluster, MASLD–CVD interactions) over a pure cardiology framing.


---

## Verification
- **Source:** https://www.sciencedirect.com/journal/nutrition-metabolism-and-cardiovascular-diseases/publish/guide-for-authors
- **Date (harvested from a local profile library):** 2026-05
- **Date (promoted to public):** 2026-05-21

# PLOS Medicine

## Identity
- **Abbreviation:** PLoS Med
- **Publisher:** Public Library of Science (PLOS)
- **ISSN:** 1549-1277 / 1549-1676
- **Homepage:** https://journals.plos.org/plosmedicine/
- **Author guidelines:** https://journals.plos.org/plosmedicine/s/submission-guidelines

## Scope
PLOS Medicine publishes research and commentary of general interest to the international medical and public health communities. It favors studies with broad implications for clinical practice, health policy, or global health, particularly those addressing health equity, disease burden, and evidence synthesis.

## Scope Keywords
global health, public health, epidemiology, health policy, clinical trials, meta-analysis, systematic review, health equity, infectious disease, non-communicable disease, evidence synthesis, health systems, screening, prevention, population health

## Article Types Accepted
- Research Article
- Meta-Research Article
- Systematic Review and Meta-Analysis
- Essay
- Perspective
- Editorial
- Collection Review
- Guidelines and Guidance

## Classification
- **Tier:** Q1
- **Open Access:** Full OA
- **Field:** General medicine / Public health

## Special Notes
PLOS Medicine is fully open access and charges an article processing charge. It is particularly strong in systematic reviews, meta-analyses, and global health studies. The journal requires a data availability statement and encourages preregistration. It has a dedicated interest in meta-research (research on research) and reporting guideline adherence.

# Radiology

## Identity
- **Abbreviation:** Radiology
- **Publisher:** Radiological Society of North America (RSNA)
- **ISSN:** 0033-8419 / 1527-1315
- **Homepage:** https://pubs.rsna.org/journal/radiology
- **Author guidelines:** https://pubs.rsna.org/page/radiology/submission-guidelines

## Scope
Radiology is the flagship journal of radiology, publishing practice-changing original research and reviews across all imaging modalities and subspecialties, with emphasis on large multi-center studies, prospective designs, and clinically validated AI applications.

## Scope Keywords
diagnostic radiology, interventional radiology, CT, MRI, ultrasound, PET, nuclear medicine, oncologic imaging, cardiovascular imaging, thoracic imaging, abdominal imaging, neuroradiology, musculoskeletal imaging, AI clinical validation, imaging biomarkers, multi-center trials, screening

## Article Types Accepted
- Original Research
- Review Article
- Technical Developments
- Case Report
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (RSNA Open Access)
- **Field:** Radiology (general, flagship)

## Special Notes
Radiology (IF ~19) is the highest-impact general radiology journal with approximately 5-8% acceptance rate. Requires a Summary Statement (single sentence, <=50 words) and 3 Advances in Knowledge bullets. Strictly enforces a 6-figure limit. Expects large sample sizes (N >= 200 typical, N >= 500 preferred for prospective studies). AI policy: language editing only, dual disclosure required, AI images banned.

# Radiology Case Reports

## Identity
- **Abbreviation:** Radiol Case Rep
- **Publisher:** Elsevier
- **ISSN:** 1930-0433 (electronic)
- **Homepage:** https://www.sciencedirect.com/journal/radiology-case-reports
- **Author guidelines:** https://www.sciencedirect.com/journal/radiology-case-reports/publish/guide-for-authors

## Scope
Open-access journal dedicated to case reports in **radiology and medical imaging** across all modalities (radiography, ultrasound, CT, MRI, nuclear medicine/PET, interventional). Best fit for cases whose teaching point is an imaging finding, a cross-modality discordance, an interventional complication, or a rare imaging presentation.

## Scope Keywords
radiology case report, imaging findings, CT, MRI, ultrasound, PET/CT, nuclear medicine, interventional radiology, rare imaging presentation, multimodality imaging, diagnostic pitfall

## Article Types Accepted
- Case Report
- Case Series
- (imaging-focused) Brief reports

## Classification
- **Tier:** Q3/Q4 (imaging case-report-dedicated)
- **Open Access:** Full gold OA, CC BY 4.0 (APC applies — verify current amount)
- **Field:** Radiology / medical imaging

## Special Notes
The natural home for a radiology trainee/fellow case whose contribution is the **image**. Expects high-quality, de-identified, annotated image panels and explicit modality-by-modality description (finding vs impression). Patient consent for publication of images is required. Pairs well with `make-figures` `exemplar_plots/imaging_panel.md`.

## Verification
Identity (Elsevier, OA/CC-BY, imaging case-report scope) verified 2026-06-15 against a current CC-BY article in the journal (Europe PMC). ISSN and submission limits not independently fetched (ScienceDirect page returned 403) — confirm ISSN and word/figure/APC details at the guide-for-authors URL before submission.

# Radiology: Artificial Intelligence

## Identity
- **Abbreviation:** Radiol Artif Intell
- **Publisher:** Radiological Society of North America (RSNA)
- **ISSN:** 2638-6100 / 2638-6100
- **Homepage:** https://pubs.rsna.org/journal/ai
- **Author guidelines:** https://pubs.rsna.org/page/ai/submission-guidelines

## Scope
Radiology: Artificial Intelligence publishes original research on AI and machine learning methodology, development, and validation in medical imaging, covering all stages from algorithm development through clinical deployment and fairness assessment.

## Scope Keywords
artificial intelligence, deep learning, machine learning, medical imaging AI, computer-aided detection, radiomics, natural language processing, large language models, convolutional neural networks, transformers, segmentation, classification, object detection, model validation, AI fairness, clinical deployment, explainability

## Article Types Accepted
- Original Research
- Technical Note
- Review Article
- Letter to the Editor

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** Radiology / Artificial intelligence

## Special Notes
Radiology: Artificial Intelligence is the premier AI-focused radiology journal (IF ~8), a sister journal to Radiology. CLAIM checklist is mandatory for all AI studies. Strong emphasis on reproducibility, requiring code availability statements and model cards. Accepts AI studies at any development stage (unlike flagship Radiology which requires full clinical validation). AI policy: language editing only, dual disclosure required, AI images banned.

## Acceptance Signals
- **Selectivity band:** highly-selective
- **Desk-reject triggers:** AI study without CLAIM compliance, code-availability statement, or model card; claims that exceed the study's validation stage; reproducibility gaps
- **Design expectations:** validation rigor proportional to the claim (external validation strengthens deployment-stage claims); methodology and leakage controls clearly reported
- **Study-type tolerance:** AI/ML methodology and validation at any development stage
- **Review process:** CLAIM checklist mandatory; code availability + model card; dual AI disclosure; AI-generated images banned
- **Cascade / transfer:** RSNA family; tier-down to a general radiology-AI or imaging-informatics journal

# Skeletal Radiology

## Identity
- **Abbreviation:** Skeletal Radiol
- **Publisher:** Springer Nature (International Skeletal Society)
- **ISSN:** 0364-2348 / 1432-2161
- **Homepage:** https://www.springer.com/journal/256
- **Author guidelines:** https://www.springer.com/journal/256/submission-guidelines

## Scope
Skeletal Radiology publishes original research, reviews, and case reports on imaging of the musculoskeletal system. Coverage includes bone and soft tissue tumors, arthritis, sports injuries, metabolic bone disease, congenital anomalies, and spinal disorders as they relate to musculoskeletal imaging across all modalities (radiography, CT, MRI, ultrasound).

## Scope Keywords
musculoskeletal imaging, bone tumor, soft tissue tumor, arthritis, sports injury, MRI musculoskeletal, bone marrow, cartilage imaging, fracture, osteoporosis, joint imaging, skeletal dysplasia, ultrasound musculoskeletal, spinal imaging, orthopedic radiology

## Article Types Accepted
- Scientific Article
- Review Article
- Case Report
- Technical Report
- Test Yourself (quiz case)
- Letter to the Editor
- Pictorial Essay

## Classification
- **Tier:** Q2
- **Open Access:** Hybrid (Springer transformative agreements)
- **Field:** Radiology / Musculoskeletal imaging

## Special Notes
Skeletal Radiology is the official journal of the International Skeletal Society and the Musculoskeletal Tumor Society (radiology section). It is one of the few radiology journals that actively publishes case reports. The journal has particular strength in musculoskeletal tumor imaging and sports medicine radiology. AI applications in MSK imaging are increasingly featured.

# Stroke (AHA/ASA)

## Identity
- **Abbreviation:** Stroke
- **Publisher:** American Heart Association / American Stroke Association (Wolters Kluwer / Lippincott)
- **ISSN:** 0039-2499 (print) / 1524-4628 (online); ISSN-L 0039-2499
- **Homepage:** https://www.ahajournals.org/journal/str
- **Author guidelines:** https://www.ahajournals.org/stroke/author-instructions
- **Submission email:** stroke@strokeahajournal.org
- **Editor-in-Chief:** Argye E. Hillis

## Scope
Stroke is the AHA/ASA's flagship cerebrovascular journal, publishing basic, translational, clinical, and population science on ischemic stroke, intracerebral and subarachnoid hemorrhage, cerebral small vessel disease, cerebrovascular imaging, acute stroke treatment (IV thrombolysis, endovascular therapy), secondary prevention, and stroke systems of care. Articles are triaged into three science categories — Basic/Translational, Clinical, and Population — at submission.

## Scope Keywords
ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, transient ischemic attack, mechanical thrombectomy, IV thrombolysis, cerebral small vessel disease, stroke epidemiology, vascular cognitive impairment, stroke recovery, stroke systems of care, cerebrovascular imaging, carotid disease, intracranial atherosclerosis, basic cerebrovascular biology

## Article Types Accepted
- Original Research (Basic/Translational, Clinical, Population)
- Brief Report
- Research Letter
- Review / Progress Review
- Emerging Therapy Critique
- Special Report
- Comments and Opinions
- Stroke Images (clinical or basic)
- Illustrative Teaching Case
- InterSECT (multi-author clinical reasoning)
- Editorial / Letter to the Editor / Response

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid (subscription + optional Gold OA)
- **Field:** Stroke / cerebrovascular disease (basic + clinical + population)

## Special Notes
The AHA/ASA flagship stroke journal. Approximately 50% rejection rate on initial review. Structured 300-word abstract for Original Research; Vancouver numbered references listing the first 10 authors followed by "et al." Original Research caps at 5000 words with up to 50 references and 8 figures/tables combined. Research Letters (750 words, 5 references, 1 figure/table, no abstract) are a fast-track format. Revision window 90 days; Graphic Abstract is required at revision stage. Acceptance of manuscript triggers entry to the AHA multi-journal portal ecosystem (ATVB, Circulation Research, Hypertension, S:VIN, JAHA) — cross-journal transfer is offered for rejected work that fits another AHA journal. AI policy is explicit: generative AI is permitted with documentation, cannot be an author (ICMJE), must be listed in Acknowledgments, documented in Methods if used in research design, exempt for grammar/spell-check only; AI image manipulation is prohibited. Choose Stroke over Journal of Stroke when target audience is global (North American + European) rather than Asia-Pacific, or when subscription/hybrid is acceptable; choose Journal of Stroke when no-APC OA is required.

# The BMJ

## Identity
- **Abbreviation:** BMJ
- **Publisher:** BMJ Group (British Medical Association)
- **ISSN:** 0959-8138 / 1756-1833
- **Homepage:** https://www.bmj.com/
- **Author guidelines:** https://www.bmj.com/about-bmj/resources-authors

## Scope
The BMJ publishes original research, reviews, and education articles across all areas of medicine with emphasis on studies relevant to clinical practice, public health policy, and evidence-based medicine. It prioritizes large observational studies, trials, and systematic reviews with broad international applicability.

## Scope Keywords
clinical trials, evidence-based medicine, public health, epidemiology, primary care, health policy, observational studies, systematic reviews, patient outcomes, medical education, health services research, global health, disease prevention, clinical guidelines, population health

## Article Types Accepted
- Research (Original Article)
- Analysis
- Clinical Review (commissioned)
- Education (commissioned)
- Practice
- Editorials
- Correspondence (Rapid Responses)

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (all research articles)
- **Field:** General medicine

## Special Notes
The BMJ is the 3rd highest-impact general medical journal (IF 93.7). It uses open peer review with prepublication history posted alongside accepted papers. Requires a "What is already known / What this study adds" summary box and mandatory patient/public involvement reporting. AI policy: all tasks permitted with disclosure, AI images must be declared.

# The Lancet

## Identity
- **Abbreviation:** Lancet
- **Publisher:** Elsevier (The Lancet Group)
- **ISSN:** 0140-6736 / 1474-547X
- **Homepage:** https://www.thelancet.com/
- **Author guidelines:** https://www.thelancet.com/publishing-with-the-lancet

## Scope
The Lancet publishes original research, reviews, and commentary on all aspects of human health, with particular emphasis on large clinical trials, global health, and studies that inform health policy. It prioritizes practice-changing evidence with immediate international relevance.

## Scope Keywords
clinical trials, global health, health policy, randomized controlled trials, epidemiology, infectious disease, chronic disease, mortality, therapeutics, public health, maternal health, child health, health systems, non-communicable diseases, clinical outcomes

## Article Types Accepted
- Article (Original Research)
- Review
- Seminar
- Series
- Comment
- Correspondence
- Viewpoint

## Classification
- **Tier:** Q1
- **Open Access:** Hybrid
- **Field:** General medicine

## Special Notes
The Lancet is the 2nd highest-impact general medical journal. It requires a mandatory "Research in Context" panel with systematic search strategy, and all figures are redrawn in-house into Lancet style. Uses midline dot (·) as decimal separator. AI policy: language editing only, dual disclosure required, AI images banned.

# The Lancet Digital Health

## Identity
- **Abbreviation:** Lancet Digit Health
- **Publisher:** Elsevier (The Lancet Group)
- **ISSN:** 2589-7500 / 2589-7500
- **Homepage:** https://www.thelancet.com/journals/landig/home
- **Author guidelines:** https://www.thelancet.com/publishing-with-the-lancet

## Scope
The Lancet Digital Health publishes original research, reviews, and commentary on digital technologies in health and medicine, including AI/ML clinical applications, telemedicine, wearable devices, electronic health records, and digital public health interventions. It emphasizes studies demonstrating real-world clinical impact of digital health tools.

## Scope Keywords
digital health, artificial intelligence, machine learning, deep learning, clinical decision support, telemedicine, wearable devices, electronic health records, medical imaging AI, diagnostic algorithms, mobile health, health informatics, digital therapeutics, prediction models, computer-aided diagnosis, natural language processing

## Article Types Accepted
- Article (Original Research)
- Review
- Comment
- Correspondence
- Viewpoint

## Classification
- **Tier:** Q1
- **Open Access:** Full OA (Gold, CC BY 4.0)
- **Field:** Medical informatics / Digital health

## Special Notes
Ranked #1 in medical informatics by Impact Factor (~24.1). Follows Lancet Group conventions including a **mandatory Research in Context panel** (with a systematic-search description), midline-dot decimal separator, and in-house figure redrawing. Requires CLAIM or TRIPOD+AI checklists for AI/ML studies and encourages code availability statements. AI policy: language editing only, Methods disclosure required per ICMJE.

Key constraints: Article body **≤3,500 w / abstract ≤300 w (5 headings) / references ≤30**; **Results and Discussion may not contain subheadings** (observational guideline); **figures must be editable vector (.eps/.pdf/.svg), not raster**; **Author Statement requires ≥2 named data-verifiers (by initials)** for observational studies; Equitable Partnership Declaration triggers only for LMIC-partnered research. Frequent, fast desk-reject (≈1–2 wk triage). **Verified 2026-06-11** against the official Information for Authors PDF.

# World Journal of Hepatology

## Identity
- **Abbreviation:** World J Hepatol
- **Publisher:** Baishideng Publishing Group Inc., Pleasanton, CA, USA
- **ISSN:** 1948-5182 (online-only)
- **Homepage:** https://www.wjgnet.com/1948-5182/index.htm
- **Author guidelines (BPG common):** https://www.wjgnet.com/bpg/gerinfo/204
- **Submission system:** F6Publishing — https://www.f6publishing.com

## Scope
World Journal of Hepatology is one of 47 peer-reviewed open-access journals of the Baishideng Publishing Group, dedicated to clinical and basic research on hepatobiliary diseases. Topical coverage includes liver cirrhosis, viral hepatitis (HBV, HCV), NAFLD/MASLD, alcohol-associated liver disease, autoimmune hepatitis, hepatocellular carcinoma, liver transplantation, and emerging biomarkers / molecular pathophysiology. Receptive to MASLD natural-history cohort studies, retrospective cohort analyses, and observational epidemiology with East-Asian or international generalizability.

## Scope Keywords
hepatology, liver disease, NAFLD, MASLD, alcoholic liver disease, ALD, MetALD, viral hepatitis, hepatitis B, hepatitis C, HCC, hepatocellular carcinoma, cirrhosis, liver fibrosis, FIB-4, retrospective cohort, observational study, biliary disease, liver transplantation, hepatobiliary

## Article Types Accepted
- Editorial (3.1)
- Frontier (3.2)
- Guidelines (3.3)
- Field of Vision (3.4)
- Opinion Review (3.5)
- Expert Consensus (3.6)
- Evidence Review (3.7)
- Review (3.8)
- Minireview (3.9)
- Case-Control Study (3.10)
- **Retrospective Cohort Study (3.11)** ← retrospective-cohort fit
- Retrospective Study (3.12)
- Clinical Trials Study (3.13)
- **Observational Study (3.14)** ← retrospective-cohort fit
- Prospective Study (3.15)
- Randomized Controlled Trial (3.16)
- Randomized Clinical Trial (3.17)
- Basic Study (3.18)
- Evidence-Based Medicine (3.19)
- Systematic Review (3.20)
- Meta-Analysis (3.21)
- Scientometrics (3.22)
- Case Report (3.23)
- Correspondence / Letter to the Editor (3.24)
- Correction / Retraction Note (3.25, 3.26)

## Classification
- **Tier:** Q3–Q4 hepatology (specialty open access; Q-tier varies year on year, verify at JCR)
- **Open Access:** Full OA, **CC BY-NC 4.0** (no commercial reuse)
- **Field:** hepatology — clinical and basic, broad Asian/international scope

## Special Notes
Baishideng publishes 47 OA journals; World Journal of Hepatology is the dedicated hepatology venue and accepts a highly granular taxonomy of study designs (each design has its own writing guidelines page, e.g. Retrospective Cohort Study at https://www.wjgnet.com/bpg/GerInfo/210, Observational Study at /200). All articles are externally peer-reviewed and selected by an in-house editor. CC BY-NC license means commercial reuse and AI-training reuse are explicitly restricted ("All rights are reserved, including those for text and data mining, AI training, and similar technologies"). 17-step editorial process is documented (initial check → peer review → editor evaluation → decision → revision → re-review → acceptance → PDF proof → publish online → peer-review report disclosure → contributor disclosure → author evaluation → article quality tracking → reader comments). APC verified at https://www.wjgnet.com/bpg/gerinfo/242 (changes; check current rate). Reference Citation Analysis (RCA) is a Baishideng-internal citation/quality tracking tool — not a substitute for JCR.

## Acceptance Rate (estimated)
~30–40 % (Baishideng OA family historically broad; World J Gastroenterol — the flagship — has reported acceptance ~30–35 % in recent years; World J Hepatol is typically slightly higher given lower submission volume).

# Challenge card — acceptance-readiness pre-flight

**Tool under test:** `skills/find-journal/scripts/assess_acceptance_readiness.py`

## What it guards
`/find-journal` ranks journals by *scope fit*. But editors apply an earlier,
decisive filter: **importance/novelty + design-ceiling**. The #1 desk-rejection
driver is lack of novelty/importance (~52%), ahead of scope; and across editor
decisions an *unfixable* design-ceiling defect floors the outcome at REJECT no
matter how polished everything fixable is. This script supplies that missing
**acceptance-feasibility** axis as a deterministic lexical pre-flight so the skill
can gate the venue TIER a manuscript's design can credibly support.

It is advisory (a risk/ceiling band with reasons), never an acceptance probability,
and never auto-fixable.

## Fixtures
- `fixture_ceiling/manuscript.md` — seeded with one signal per category:
  cross-sectional + single-center + surrogate (FIB-4) + no-external-validation +
  pilot (DESIGN_CEILING ×5), single-vendor/single-scanner (UNFIXABLE_DEFECT),
  null/negative + incremental framing (IMPORTANCE_RISK ×2), and a
  management/surveillance claim (CLAIM_MISMATCH ×1). Expected: 9 flags, verdict
  `HIGH-IMPACT VENUE UNLIKELY WITHOUT A DESIGN CHANGE`.
- `fixture_clean/manuscript.md` — a multi-center, externally-validated, prospective
  design with a hard endpoint and a comparator. It *deliberately* contains the
  management/surveillance verbs ("we recommend … guide management … surveillance")
  but **no** ceiling trigger, so the gated CLAIM_MISMATCH must stay silent.
  Expected: 0 flags, verdict `NO STRUCTURAL CEILING DETECTED BY LEXICAL SCAN`
  (the negative fixture — proves no false positives).

## Pass criterion
`verify.sh` runs the tool on both fixtures and diffs against the golden masters in
`expected/`. Exit 0 iff both match. Deterministic and network-free.

## Run
```
bash skills/find-journal/scripts/acceptance_readiness_challenge/verify.sh
```

#!/usr/bin/env bash
# Deterministic, network-free verifier for the acceptance-readiness challenge card.
# Runs assess_acceptance_readiness.py on two synthetic manuscripts:
#   - fixture_ceiling: seeded with design-ceiling / unfixable / importance / claim
#     signals -> must flag all four categories (9 flags) and the HIGH-impact verdict.
#   - fixture_clean: a strong multi-center externally-validated design that carries
#     management/surveillance verbs but NO ceiling trigger -> must flag nothing
#     (negative fixture: proves the gated CLAIM_MISMATCH does not false-fire).
# Exit 0 = both reports match their golden masters.
set -euo pipefail
HERE="$(cd "$(dirname "$0")" && pwd)"
TOOL="$HERE/../assess_acceptance_readiness.py"

status=0
for case in ceiling clean; do
  actual="$(python3 "$TOOL" "$HERE/fixture_${case}/manuscript.md")"
  if diff -u "$HERE/expected/report_${case}.txt" <(printf '%s\n' "$actual"); then
    echo "PASS: ${case} report matches expected."
  else
    echo "FAIL: ${case} report drifted from expected/report_${case}.txt" >&2
    status=1
  fi
done

if [ "$status" -eq 0 ]; then
  echo "PASS: acceptance-readiness pre-flight matches both golden masters (positive + negative)."
fi
exit "$status"